1
|
Wu LJ, Li XX, Ye F, Liu YX, Yang F, Zhou Q, Lyu YK. Ammonia stripping by in situ biogas self-circulation to upgrade continuous thermophilic and mesophilic digestion of hydrothermal high-solid sludge. Bioresour Technol 2024:130797. [PMID: 38705214 DOI: 10.1016/j.biortech.2024.130797] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/05/2024] [Revised: 05/02/2024] [Accepted: 05/02/2024] [Indexed: 05/07/2024]
Abstract
High-solid anaerobic digestion of hydrothermal sewage sludge has been developed. In order to upgrade the process by focusing on ammonia inhibition, a simply-equipped stripping system without additional alkali or heat supply was introduced by in situ biogas self-circulation. As the determined limit of total ammonia nitrogen at 1500 mg/L and 1000 mg/L for the mesophilic (MAD) and thermophilic anaerobic digestion (TAD) respectively and stripping rate at 5 L/min, continuous MAD and TAD was conducted in parallel. The stripping system successfully polished up the ammonia inhibition, and methanogenic capability of the TAD was promoted to approximately 90.0 % of the potential. Intermittent stripping mode proved usable. More frequent stripping was inevitable for the TAD as compared to the MAD. Hydraulic retention time below 20 d resulted in failure of the stripping mode due to rapid ammonia generation. Overall, this technology was practical in upgrading high-solid sludge digestion by effective ammonia control.
Collapse
Affiliation(s)
- Li-Jie Wu
- State Key Laboratory of Clean and Efficient Coal Utilization, College of Chemical Engineering and Technology, Taiyuan University of Technology, Taiyuan 030024, Shanxi, China; Key Laboratory of Coal Science and Technology of Ministry of Education, College of Chemical Engineering and Technology, Taiyuan University of Technology, Taiyuan 030024, Shanxi, China.
| | - Xiao-Xiao Li
- College of Environmental Science and Engineering, Taiyuan University of Technology, Jinzhong 030600, Shanxi, China
| | - Fei Ye
- State Key Laboratory of Clean and Efficient Coal Utilization, College of Chemical Engineering and Technology, Taiyuan University of Technology, Taiyuan 030024, Shanxi, China; Key Laboratory of Coal Science and Technology of Ministry of Education, College of Chemical Engineering and Technology, Taiyuan University of Technology, Taiyuan 030024, Shanxi, China
| | - Yu-Xiang Liu
- College of Environmental Science and Engineering, Taiyuan University of Technology, Jinzhong 030600, Shanxi, China
| | - Fan Yang
- State Key Laboratory of Clean and Efficient Coal Utilization, College of Chemical Engineering and Technology, Taiyuan University of Technology, Taiyuan 030024, Shanxi, China; Key Laboratory of Coal Science and Technology of Ministry of Education, College of Chemical Engineering and Technology, Taiyuan University of Technology, Taiyuan 030024, Shanxi, China
| | - Quan Zhou
- State Key Laboratory of Clean and Efficient Coal Utilization, College of Chemical Engineering and Technology, Taiyuan University of Technology, Taiyuan 030024, Shanxi, China; Key Laboratory of Coal Science and Technology of Ministry of Education, College of Chemical Engineering and Technology, Taiyuan University of Technology, Taiyuan 030024, Shanxi, China
| | - Yong-Kang Lyu
- State Key Laboratory of Clean and Efficient Coal Utilization, College of Chemical Engineering and Technology, Taiyuan University of Technology, Taiyuan 030024, Shanxi, China; Key Laboratory of Coal Science and Technology of Ministry of Education, College of Chemical Engineering and Technology, Taiyuan University of Technology, Taiyuan 030024, Shanxi, China
| |
Collapse
|
2
|
Liu YX, Gu HY, Li GQ, Li D, Wang JN, Li XQ, Kong WM, Wang JG. [Clinicopathological analysis of papillary thyroid carcinoma in adults with receptor tyrosine kinase rearrangement]. Zhonghua Bing Li Xue Za Zhi 2024; 53:390-392. [PMID: 38556825 DOI: 10.3760/cma.j.cn112151-20230902-00122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/02/2024]
Affiliation(s)
- Y X Liu
- Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao 266555, China
| | - H Y Gu
- Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao 266555, China
| | - G Q Li
- Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao 266555, China
| | - D Li
- Department of Pathology, Qingdao Municipal Hospital, Qingdao 266071, China
| | - J N Wang
- Department of Pathology, College of Basic Medical Sciences, Qingdao University, Qingdao 266071, China
| | - X Q Li
- Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao 266555, China
| | - W M Kong
- Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao 266555, China
| | - J G Wang
- Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao 266555, China
| |
Collapse
|
3
|
Hui HZ, Guo HX, Wang YJ, Yu Y, Liu YX, Liu H, Shi BJ. Camrelizumab-induced reactive cutaneous capillary endothelial proliferation followed by tislelizumab-induced erythema multiforme in a patient with acute myeloid leukemia. Int J Dermatol 2024; 63:251-253. [PMID: 38031284 DOI: 10.1111/ijd.16945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/18/2022] [Revised: 09/10/2023] [Accepted: 11/17/2023] [Indexed: 12/01/2023]
Affiliation(s)
- Hai-Zhen Hui
- Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine (Chongqing Clinical Research Center for Dermatology; Chongqing Key Laboratory of Integrative Dermatology Research), Chongqing, P.R. China
| | - Hong-Xing Guo
- Department of General Surgery, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, P.R. China
| | - Ying-Jun Wang
- Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine (Chongqing Clinical Research Center for Dermatology; Chongqing Key Laboratory of Integrative Dermatology Research), Chongqing, P.R. China
| | - Yin Yu
- Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine (Chongqing Clinical Research Center for Dermatology; Chongqing Key Laboratory of Integrative Dermatology Research), Chongqing, P.R. China
| | - Yu-Xiang Liu
- The Second People's Hospital of Guizhou Province, Guiyang, P.R. China
| | - Hua Liu
- Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine (Chongqing Clinical Research Center for Dermatology; Chongqing Key Laboratory of Integrative Dermatology Research), Chongqing, P.R. China
| | - Bing-Jun Shi
- Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine (Chongqing Clinical Research Center for Dermatology; Chongqing Key Laboratory of Integrative Dermatology Research), Chongqing, P.R. China
| |
Collapse
|
4
|
Su NY, Shi Q, Mei H, Hu J, Liu YX, Liu HN, Liu HQ, Guo Y, Wang XW, Lan CH. Efficacy and safety of vonoprazan-based dual therapy and esomeprazole-based dual therapy in eradicating primary Helicobacter pylori infection: A propensity score matching analysis. Helicobacter 2023; 28:e13003. [PMID: 37565458 DOI: 10.1111/hel.13003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Revised: 05/25/2023] [Accepted: 06/14/2023] [Indexed: 08/12/2023]
Abstract
BACKGROUND According to the Maastricht VI/Florence consensus report, potassium-competitive acid blockers (P-CAB) may improve Helicobacter pylori eradication treatment. MATERIALS AND METHODS A total of 213 H. pylori treatment-naive patients aged between 18 and 70 years were treated with two regimens. The two regimens are VDT: 20 mg vonoprazan twice a day and 1 g amoxicillin three times daily and EDT: 20 mg esomeprazole four times a day and 750 mg amoxicillin four times daily. 13 C-urea breath tests were used to evaluate eradication rate 4-6 weeks after treatment. Based on propensity score matching (PSM), this retrospective study analyzed the eradication rates, adverse events (AEs), compliance, and antibiotic resistance rates in VDT and EDT groups. RESULTS On intention-to-treat (ITT) analysis, the eradication rate in VDT group (89.0%; 95% CI 81.7-96.3) was non-inferior to that in EDT group (87.7%; 95% CI 80.1-95.3; p = 0.796). The corresponding per-protocol (PP) eradication rates were 94.1% (95% CI 88.4-99.8) and 92.8% (95% CI 86.7-98.9; p = 1.000), respectively. There were no significant between-group differences with respect to compliance or incidence of AEs. CONCLUSIONS The efficacy and safety of 14-day VDT and EDT were comparable. Therefore, 14-day VDT or EDT may be recommended for the first-line treatment of H. pylori infection.
Collapse
Affiliation(s)
- Na-Yun Su
- Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University, Third Military Medical University, Chongqing, China
| | - Qing Shi
- Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University, Third Military Medical University, Chongqing, China
| | - Hao Mei
- Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University, Third Military Medical University, Chongqing, China
| | - Jie Hu
- Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University, Third Military Medical University, Chongqing, China
| | - Yu-Xiang Liu
- Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University, Third Military Medical University, Chongqing, China
| | - Han-Ning Liu
- Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University, Third Military Medical University, Chongqing, China
| | - Heng-Qi Liu
- Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University, Third Military Medical University, Chongqing, China
| | - Yan Guo
- Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University, Third Military Medical University, Chongqing, China
| | - Xing-Wei Wang
- Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University, Third Military Medical University, Chongqing, China
| | - Chun-Hui Lan
- Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University, Third Military Medical University, Chongqing, China
| |
Collapse
|
5
|
Gu JC, Liu Y, Wang XL, Zhang LL, Liu YX. [Disease burden and prediction of oral cancer attributable to smoking in China from 1990 to 2019]. Zhonghua Kou Qiang Yi Xue Za Zhi 2023; 58:919-925. [PMID: 37659850 DOI: 10.3760/cma.j.cn112144-20221020-00544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 09/04/2023]
Abstract
Objective: To analyze the trend of disease burden of oral cancer attributable to smoking in China from 1990 to 2019, and predict the mortality trend of oral cancer from 2020 to 2034, providing scientific basis for formulating targeted oral cancer prevention and treatment strategy to achieve the goal of "Healthy China 2030". Methods: Using partial data on the global burden of disease in China in 2019, attributive death and disability adjusted life year (DALY) were used to describe. The trend of changes in the burden of oral cancer disease attributed to smoking was analyzed by using the Joinpoint regression model to estimate the annual average percentage change (AAPC) of age standardized mortality and DALY rates. Meanwhile, the Bayesian age-period- cohort model is used to predict oral cancer deaths and DALY trends attributed to smoking over the next 15 years. Results: The age-standardized mortality rate and DALY rate in China from 1990 to 2019 showed an overall upward trend, with an average annual increase of 1.49% (95%CI: 1.34%-1.65%, P<0.001) and 1.41% (95%CI: 1.24%-1.59%, P<0.001) respectively, higher than around the earth and in regions with different socio-demographic index (SDI). In 2019, 46.74% (10 584/22 642) of oral cancer deaths in China were attributed to smoking. Compared to 1990, the number of attributed deaths in 2019 increased by 293.75% (7 896/2 688), while DALY increased by 257.97% (189 039/73 280). Moreover, the growth rates of attributed deaths and DALY in males [304.95% (7 584/2 487) and 265.60% (183 349/69 033), respectively] were significantly higher than those in females [154.73% (311/201) and 133.95% (5 690/4 248), respectively] (P<0.001). The age group results showed that the proportion of deaths and DALY gradually transitioned towards the elderly (>60 years old). The expected number of deaths would increase from 10 731 in 2020 to 14 125 in 2034, with a rise of 31.63% (3 394/10 731). Simultaneously, DALY would increase from 267 064 person years in 2020 to 326 634 person years in 2034, with a rise of 22.31% (59 570/267 064). Conclusions: From 1990 to 2019, the burden of oral cancer diseases attributed to smoking in China showed an increasing trend, with a higher growth rates than in the global and different SDI regions. There were differences in gender and age, and the burden of oral cancer diseases attributed to smoking in China would continue to increase in the next 15 years. It is necessary to educate on the adverse effects of tobacco consumption and to conduct vigilant oral self-examination among high-risk groups to help early detection and intervention at the same time.
Collapse
Affiliation(s)
- J C Gu
- School of Stomatology, Weifang Medical University, Weifang 261053, China
| | - Y Liu
- School of Stomatology, Weifang Medical University, Weifang 261053, China
| | - X L Wang
- School of Stomatology, Weifang Medical University, Weifang 261053, China
| | - L L Zhang
- School of Stomatology, Weifang Medical University, Weifang 261053, China
| | - Y X Liu
- School of Stomatology, Weifang Medical University, Weifang 261053, China
| |
Collapse
|
6
|
Liu YX, Yang G, Hu XK, Tan Q, Pan H, Liu K, Huang YY, Yan A, Zhu GH, Mei HB. [Long term follow-up evaluation of combined surgery for congenital tibial pseudarthrosis in children]. Zhonghua Wai Ke Za Zhi 2023; 61:675-680. [PMID: 37400210 DOI: 10.3760/cma.j.cn112139-20230205-00051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 07/05/2023]
Abstract
Objective: To explore the long-term effect of combined surgery for the treatment of congenital tibial pseudarthrosis in children. Methods: The clinical data of 44 children with congenital tibial pseudarthrosis who underwent combined surgery (tibial pseudarthrosis tissue resection, intramedullary rod fixation, Ilizarov external fixator fixation, wrapped autologous iliac bone graft) from August 2007 to October 2011 at the Department of Pediatric Orthopedics, Hunan Children's Hospital were collected retrospectively. There were 33 males and 11 females. The age at the time of surgery was (3.7±2.2)years (range:0.6 to 12.4 years), including 25 cases under 3 years old and 19 cases above 3 years old.Among them, 37 cases were complicated with neurofibromatosis type 1.The operation status, postoperative complications and follow-up results were recorded. Results: The follow-up time after surgery was (10.9±0.7)years (range:10 to 11 years).Thirty-nine out of 44 patients (88.6%) achieved initial healing of tibial pseudarthrosis, with an average healing time of (4.3±1.1)months (range:3 to 10months).In the last follow-up, 36 cases (81.8%) had unequal tibial length, 20 cases (45.4%) had refractures, 18 cases (40.9%) had ankle valgus, 9 cases (20.4%) had proximal tibial valgus, and 11 cases (25.0%) had high arched feet.Nine cases (20.4%) developed distal tibial epiphyseal plate bridging.17 cases (38.6%) had abnormal tibial mechanical axis.Seven cases (15.9%) developed needle infection, and one case (2.3%) developed tibial osteomyelitis. 21 patients (47.7%) had excessive growth of the affected femur.Five patients (11.3%) had ankle stiffness, and 34 patients (77.2%) had intramedullary rod displacement that was not in the center of the tibial medullary cavity.Among them, 8 cases (18.1%) protruded the tibial bone cortex and underwent intramedullary rod removal.18 children have reached skeletal maturity, while 26 children have not been followed up until skeletal maturity. Conclusion: Combined surgery for the treatment of congenital pseudarthrosis of the tibia in children has a high initial healing rate, but complications such as unequal tibia length, refracture, and ankle valgus occur during long-term follow-up, requiring multiple surgical treatments.
Collapse
Affiliation(s)
- Y X Liu
- Department of Pediatric Orthopedics, Hunan Children's Hospital;the School of Pediatrics, University of South China, Changsha 410007, China
| | - G Yang
- Department of Pediatric Orthopedics, Hunan Children's Hospital;the School of Pediatrics, University of South China, Changsha 410007, China
| | - X K Hu
- Department of Pediatric Orthopedics, Hunan Children's Hospital;the School of Pediatrics, University of South China, Changsha 410007, China
| | - Q Tan
- Department of Pediatric Orthopedics, Hunan Children's Hospital;the School of Pediatrics, University of South China, Changsha 410007, China
| | - H Pan
- Department of Pediatric Orthopedics, Hunan Children's Hospital;the School of Pediatrics, University of South China, Changsha 410007, China
| | - K Liu
- Department of Pediatric Orthopedics, Hunan Children's Hospital;the School of Pediatrics, University of South China, Changsha 410007, China
| | - Y Y Huang
- Department of Pediatric Orthopedics, Hunan Children's Hospital;the School of Pediatrics, University of South China, Changsha 410007, China
| | - A Yan
- Department of Pediatric Orthopedics, Hunan Children's Hospital;the School of Pediatrics, University of South China, Changsha 410007, China
| | - G H Zhu
- Department of Pediatric Orthopedics, Hunan Children's Hospital;the School of Pediatrics, University of South China, Changsha 410007, China
| | - H B Mei
- Department of Pediatric Orthopedics, Hunan Children's Hospital;the School of Pediatrics, University of South China, Changsha 410007, China
| |
Collapse
|
7
|
Du LM, Hu SJ, Chen XM, Deng YY, Yong HL, Shi RC, Liu JG, Cao ZZ, You YJ, Liu YX, Ma SC, Ma LK, Li XF, Li XM, Hou JB, Ye ZC, Sang T, Cao Y, Liu H, Wei XX, Hu AL, Li YL, Gao HJ. [Survey of Helicobacter pylori levofloxacin and clarithromycin resistance rates and drug resistance genes in Ningxia, 2020-2022]. Zhonghua Yi Xue Za Zhi 2023; 103:2163-2167. [PMID: 37482728 DOI: 10.3760/cma.j.cn112137-20230214-00206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 07/25/2023]
Abstract
Objective: To explore the rate of Helicobacter pylori (Hp) resistance to levofloxacin and clarithromycin and the common mutation patterns of resistance genes in Ningxia, and to assess the concordance between phenotypic resistance and genotypic resistance. Methods: Cross-sectional study. Patients diagnosed with Hp infection in 14 hospitals in Ningxia region from February 2020 to May 2022 were retrospectively selected. Hp strains were isolated from gastric biopsy specimens of Hp-infected patients and subjected to phenotypic drug sensitivity testing and detection of resistance genes to analyze the rate of Hp resistance to levofloxacin and clarithromycin and the common mutation patterns of resistance genes in Ningxia region; and the concordance rate and Kappa concordance test were used to assess the concordance between phenotypic resistance and genotypic resistance. Results: A total of 1 942 Hp strains were isolated and cultured, and among the infections, 1 069 cases (55.0%) were male and 873 cases (45.0%) were female, aged (50.0±12.5) years (15-86 years). The rates of Hp resistance to levofloxacin and clarithromycin in Ningxia were 42.1% (818/1 942) and 40.1% (779/1 942), respectively, and the rate of dual resistance to both was 22.8% (443/1 942). The rate of resistance to levofloxacin and clarithromycin of Hp strains from female patients was higher than in male patients (levofloxacin: 50.4%(440/873) vs 35.4%(378/1 069); clarithromycin: 44.4%(388/873) vs 36.6%(391/1 069), both P<0.001). Among the GyrA gene mutations associated with levofloxacin resistance, the differences in mutation rate of amino acid at positions 87 and 91 were statistically significant in both drug-resistant and sensitive strains(both P<0.001), except for Asn87Thr. Hp strains were statistically significant for levofloxacin (Kappa=0.834, P<0.001) and clarithromycin (Kappa=0.829, P<0.001) had good concordance in resistance at the phenotypic and genotypic levels. Conclusion: The resistance of Hp to levofloxacin and clarithromycin in Ningxia region is severe, and there is good consistency between genotypic and phenotypic resistance.
Collapse
Affiliation(s)
- L M Du
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - S J Hu
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - X M Chen
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - Y Y Deng
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - H L Yong
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - R C Shi
- Department of Gastroenterology, Wuzhong People's Hospital, Wuzhong 751199, China
| | - J G Liu
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - Z Z Cao
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - Y J You
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - Y X Liu
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - S C Ma
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - L K Ma
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - X F Li
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - X M Li
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - J B Hou
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - Z C Ye
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - T Sang
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - Y Cao
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - H Liu
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - X X Wei
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - A L Hu
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - Y L Li
- Department of Gastroenterology, the Third Clinical Medical College of Ningxia Medical University, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750002, China
| | - H J Gao
- Department of Gastroenterology, Tongji Hospital, Tongji University, Institute of Digestive Disease, School of Medicine, Tongji University, Shanghai 200120, China
| |
Collapse
|
8
|
Xu JJ, Chen J, Liu YX, Song Y, Jiang L, Yan SD, Guo WY, Yao Y, Jia SD, Yuan DS, Wang PZ, Li JX, Zhao XY, Liu ZY, Yuan JQ. [The impact of LDL-C/HDL-C ratio on severity of coronary artery disease and 2-year outcome in patients with premature coronary heart disease: results of a prospective, multicenter, observational cohort study]. Zhonghua Xin Xue Guan Bing Za Zhi 2023; 51:702-708. [PMID: 37460423 DOI: 10.3760/cma.j.cn112148-20230128-00043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 07/20/2023]
Abstract
Objective: To explore the relationship between low density lipoprotein cholesterol (LDL-C)/high density lipoprotein cholesterol (HDL-C) ratio with the severity of coronary artery disease and 2-yeat outcome in patients with premature coronary heart disease. Methods: This prospective, multicenter, observational cohort study is originated from the PROMISE study. Eighteen thousand seven hundred and one patients with coronary heart disease (CHD) were screened from January 2015 to May 2019. Three thousand eight hundred and sixty-one patients with premature CHD were enrolled in the current study. According to the median LDL-C/HDL-C ratio (2.4), the patients were divided into two groups: low LDL-C/HDL-C group (LDL-C/HDL-C≤2.4, n=1 867) and high LDL-C/HDL-C group (LDL-C/HDL-C>2.4, n=1 994). Baseline data and 2-year major adverse cardiovascular and cerebrovascular events (MACCE) were collected and analyzed in order to find the differences between premature CHD patients at different LDL-C/HDL-C levels, and explore the correlation between LDL-C/HDL-C ratio with the severity of coronary artery disease and MACCE. Results: The average age of the low LDL-C/HDL-C ratio group was (48.5±6.5) years, 1 154 patients were males (61.8%); the average age of high LDL-C/HDL-C ratio group was (46.5±6.8) years, 1 523 were males (76.4%). The number of target lesions, the number of coronary artery lesions, the preoperative SNYTAX score and the proportion of three-vessel coronary artery disease in the high LDL-C/HDL-C group were significantly higher than those in the low LDL-C/HDL-C group (1.04±0.74 vs. 0.97±0.80, P=0.002; 2.04±0.84 vs. 1.85±0.84, P<0.001; 13.81±8.87 vs. 11.70±8.05, P<0.001; 36.2% vs. 27.4%, respectively, P<0.001). Correlation analysis showed that there was a significant positive correlation between LDL-C/HDL-C ratio and preoperative SYNTAX score, the number of coronary artery lesions, the number of target lesions and whether it was a three-vessel coronary artery disease (all P<0.05). The 2-year follow-up results showed that the incidence of MACCE was significantly higher in the high LDL-C/HDL-C group than that in the low LDL-C/HDL-C group (6.9% vs. 9.1%, P=0.011). There was no significant difference in the incidence of all-cause death, cardiac death, myocardial infarction, stroke, revascularization and bleeding between the two groups. Cox multivariate regression analysis showed that the LDL-C/HDL-C ratio has no correlation with 2-year MACCE, death, myocardial infarction, revascularization, stroke and bleeding events above BARC2 in patients with premature CHD. Conclusion: High LDL-C/HDL-C ratio is positively correlated with the severity of coronary artery disease in patients with premature CHD. The incidence of MACCE of patients with high LDL-C/HDL-C ratio is significantly higher during 2 years follow-up; LDL-C/HDL-C ratio may be an indicator for evaluating the severity of coronary artery disease and long-term prognosis in patients with premature CHD.
Collapse
Affiliation(s)
- J J Xu
- Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - J Chen
- Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen 518057, China
| | - Y X Liu
- Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China
| | - Y Song
- Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - L Jiang
- Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - S D Yan
- Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen 518057, China
| | - W Y Guo
- Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen 518057, China
| | - Y Yao
- Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - S D Jia
- Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - D S Yuan
- Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - P Z Wang
- Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - J X Li
- Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - X Y Zhao
- Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - Z Y Liu
- Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China
| | - J Q Yuan
- Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| |
Collapse
|
9
|
Geng X, Yang Y, Wen XT, Long HF, Li YX, Liu YX, Mao ZF. [Comprehensive clinical evaluation of bedaquiline in the treatment of multidrug-resistant tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 2023; 46:572-579. [PMID: 37278171 DOI: 10.3760/cma.j.cn112147-20221031-00859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Objective: To assess the clinical value of bedaquiline in five dimensions: effectiveness, safety, economics, appropriateness, and social benefits, to provide a reference for medical and health insurance-related decisions. Methods: A total of 792 patients with multidrug-resistant tuberculosis who were hospitalized at Wuhan Pulmonary Hospital, Ganzhou Fifth People's Hospital and Jiangxi Chest Hospital between January 2018 and December 2020 were included in the study. Based on a retrospective survey of case data, and each evaluation dimension of bedaquiline was statistically analyzed by causal analysis or chi-square test, using linezolid as the reference drug. Results: In terms of effectiveness, bedaquiline significantly increased treatment success by 23.9% (95%CI:4.8%-43.0%) and shortened treatment duration by 64 days(95%CI:18-109 days). In terms of safety, the incidence of adverse reactions to bedaquiline and the discontinuation rate of adverse reactions (5.11%,4.55%) were significantly lower than those for linezolid (22.49%,15.24%), with statistically significant differences (χ2=27.50,P<0.001;χ2=14.09,P<0.001). In terms of economics, patients treated with bedaquiline had a significantly higher anti-TB drug course cost of RMB 48 209.4 Yuan(95%CI: 28 336.0-68 082.8 Yuan). In terms of appropriateness, the proportion of bedaquiline in patients' initial treatment regimens was lower than that of linezolid (16.7% vs. 86.5%) in the 2020 observation sample, with a statistically significant difference (χ2=238.96,P<0.001). In terms of social benefits, the infection control rate was significantly increased by 27.8% (95%CI:8.2%-47.5%) in patients using bedaquiline. Conclusions: Bedaquiline performed well in terms of efficacy, safety, and social benefits. However, it was less economical and the actual use rate of bedaquiline in clinical practice was lower than that of its counterpart drug, linezolid. Price reductions might be needed to increase the clinical use and performance of bedaquiline in the future.
Collapse
Affiliation(s)
- X Geng
- School of Public Health, Wuhan University, Wuhan 430071, China
| | - Y Yang
- School of Public Health, Wuhan University, Wuhan 430071, China
| | - X T Wen
- School of Public Health, Wuhan University, Wuhan 430071, China
| | - H F Long
- Dong Fureng Institute for Economic and Social Development, Wuhan University, Wuhan 430071, China
| | - Y X Li
- School of Public Health, Wuhan University, Wuhan 430071, China
| | - Y X Liu
- Dong Fureng Institute for Economic and Social Development, Wuhan University, Wuhan 430071, China
| | - Z F Mao
- School of Public Health, Wuhan University, Wuhan 430071, China
| |
Collapse
|
10
|
Liu YX, Yu HQ, Li HW. [Interpretation of guidelines/statements/consensus on idiopathic sudden sensorineural hearing loss]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2023; 58:637-642. [PMID: 37339908 DOI: 10.3760/cma.j.cn115330-20221020-00619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 06/22/2023]
Affiliation(s)
- Y X Liu
- Center for Otology, Department of Otorhinolaryngology, ENT Institute, Eye & ENT Hospital of Fudan University, NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai 200031, China
| | - H Q Yu
- Center for Otology, Department of Otorhinolaryngology, ENT Institute, Eye & ENT Hospital of Fudan University, NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai 200031, China
| | - H W Li
- Center for Otology, Department of Otorhinolaryngology, ENT Institute, Eye & ENT Hospital of Fudan University, NHC Key Laboratory of Hearing Medicine (Fudan University), Shanghai 200031, China
| |
Collapse
|
11
|
Hu J, Mei H, Su NY, Sun WJ, Zhang DK, Fan LL, He P, Pan J, Wang XW, Zou PY, Liu YX, Guo Y, Lan CH. Eradication rates of Helicobacter pylori in treatment-naive patients following 14-day vonoprazan-amoxicillin dual therapy: A multicenter randomized controlled trial in China. Helicobacter 2023:e12970. [PMID: 37160689 DOI: 10.1111/hel.12970] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/11/2023] [Revised: 02/26/2023] [Accepted: 03/02/2023] [Indexed: 05/11/2023]
Abstract
BACKGROUND Potassium-competitive acid blockers (P-CAB) are recommended for the treatment of Helicobacter pylori infections, but dual therapy of P-CAB with amoxicillin has been poorly studied. The current study compared the efficacy, adverse reactions, compliance, and effects on gut microbiota of 14-day vonoprazan-amoxicillin (VA) dual therapy with esomeprazole, bismuth potassium citrate, amoxicillin, and metronidazole (EBAM) quadruple therapy in treatment-naive patients with H. pylori. MATERIALS AND METHODS This was a multicenter, open-label, randomized, and controlled, non-inferiority study. Patients (n = 194) enrolled from six centers were randomly divided into either the VA or EBAM group. H. pylori eradication was determined using 13 C urea breath tests (UBT) 4-6 weeks post-treatment. Fecal samples were collected, and gut microbial populations were analyzed by 16S rDNA and metagenomic sequencing technology. RESULTS Eradication rates of H. pylori in the VA and EBAM groups were 88.7% and 91.8%, respectively, according to intention-to-treat (ITT) analysis; 95.6% and 96.7% with per-protocol (PP) analysis; and 94.5% and 96.7% with modified ITT (mITT) analysis (all p > 0.05). The incidence of adverse reactions in the VA group was significantly lower compared to the EBAM group, and compliance within both groups was good. There was no difference in α-diversity or microbial composition in the VA and EBAM groups at one-month post-treatment compared to baseline, except for a markedly reduced abundance of Bacteroides in the EBAM group. CONCLUSION VA therapy achieved excellent eradication rates with low adverse reactions, good compliance, and little impact on gut microbiota. VA therapy should be recommended as a first-line treatment against H. pylori.
Collapse
Affiliation(s)
- Jie Hu
- Department of Gastroenterology, Daping Hospital, Army Medical University, Chongqing, China
| | - Hao Mei
- Department of Gastroenterology, Daping Hospital, Army Medical University, Chongqing, China
| | - Na-Yun Su
- Department of Gastroenterology, Daping Hospital, Army Medical University, Chongqing, China
| | - Wen-Jing Sun
- Department of Gastroenterology, The 13th People's Hospital of Chongqing, Chongqing, China
| | - De-Kui Zhang
- Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou, China
| | - Li-Lin Fan
- Department of Gastroenterology, The Second People's Hospital of Chongqing, Chongqing, China
| | - Ping He
- Department of Gastroenterology, Yongchuan Hospital Affiliated to Chongqing Medical University, Chongqing, China
| | - Jie Pan
- Department of Gastroenterology, Wenzhou Central Hospital, Wenzhou, China
| | - Xing-Wei Wang
- Department of Gastroenterology, Daping Hospital, Army Medical University, Chongqing, China
| | - Pei-Ying Zou
- Department of Gastroenterology, Daping Hospital, Army Medical University, Chongqing, China
| | - Yu-Xiang Liu
- Department of Gastroenterology, Daping Hospital, Army Medical University, Chongqing, China
| | - Yan Guo
- Department of Gastroenterology, Daping Hospital, Army Medical University, Chongqing, China
| | - Chun-Hui Lan
- Department of Gastroenterology, Daping Hospital, Army Medical University, Chongqing, China
| |
Collapse
|
12
|
Yao ZZ, Yan JX, Xu NA, Kang RT, Li XW, Zhou HX, Dai W, Ouyang SS, Liu YX, Luo JY, Zhong Y. [Study on related factors and characteristics of multimorbidity of overweight and obesity-related diseases in children in Hunan Province]. Zhonghua Yu Fang Yi Xue Za Zhi 2023; 57:747-752. [PMID: 37165822 DOI: 10.3760/cma.j.cn112150-20220707-00692] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
From January 2019 to December 2021, overweight and obese children who visited in health outpatient Center of Hunan Children's Hospital were studied to explore and analyze the rate, related factors and patterns of multimorbidity of overweight and obesity-related diseases in children in Hunan Province. Univariate and multivariate logistic regression models were used to analyze the multimorbidity-related factors of overweight and obesity-related diseases in children. Association rules (apriori algorithm) were used to explore the multimorbidity patterns of overweight and obesity-related diseases in children. A total of 725 overweight and obese children were included in this study. The multimorbidity rate of overweight and obesity-related diseases in children was 46.07% (334/725). Age, waist circumference, the frequency of food consumption such as hamburgers and fries and adding meals before bedtime were multimorbidity-related factors of overweight and obesity-related diseases in children. The multimorbidity associated with nonalcoholic fatty liver disease (NAFLD) was relatively common. The patterns with the top three support degrees were "NAFLD+dyslipidemia","NAFLD+hypertension" and "NAFLD+hyperuricemia". The patterns with the top three confidence and elevation degrees were "Hypertension+dyslipidemia => NAFLD","Hyperuricemia => NAFLD" and "NAFLD+hypertension => dyslipidemia".
Collapse
Affiliation(s)
- Z Z Yao
- Department of Maternal and Children Care, Xiangya School of Public Health, Central South University, Changsha 410008, China
| | - J X Yan
- Department of Maternal and Children Care, Xiangya School of Public Health, Central South University, Changsha 410008, China
| | - N A Xu
- Department of Children Care, Hunan Children's Hospital, Changsha 410008, China
| | - R T Kang
- Department of Children Care, Hunan Children's Hospital, Changsha 410008, China
| | - X W Li
- Department of School health, Ningxiang Center for Disease Control and Prevention, Changsha 410008, China
| | - H X Zhou
- Department of School health, Ningxiang Center for Disease Control and Prevention, Changsha 410008, China
| | - W Dai
- Department of Maternal and Children Care, Xiangya School of Public Health, Central South University, Changsha 410008, China
| | - S S Ouyang
- Department of Maternal and Children Care, Xiangya School of Public Health, Central South University, Changsha 410008, China
| | - Y X Liu
- Department of Maternal and Children Care, Xiangya School of Public Health, Central South University, Changsha 410008, China
| | - J Y Luo
- Department of Maternal and Children Care, Xiangya School of Public Health, Central South University, Changsha 410008, China
| | - Y Zhong
- Department of Children Care, Hunan Children's Hospital, Changsha 410008, China
| |
Collapse
|
13
|
Shen Q, Liu YX, He Q. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis]. Beijing Da Xue Xue Bao Yi Xue Ban 2023; 55:276-282. [PMID: 37042138 PMCID: PMC10091246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 04/13/2023]
Abstract
OBJECTIVE To investigate and summarize the clinicopathological features, immunophenotype, differential diagnosis and prognosis analysis of mucinous tubular and spindle cell carcinoma (MTSCC). METHODS The data of thirteen cases of MTSCC were retrospectively analyzed, the clinical and pathological characteristics and immunohistochemical expression were summarized, and fluorescence in situ hybridization was detected. RESULTS Among the thirteen patients, four were males and nine females, with a male-to-female ratio of 1 ∶2.25. The average age was 57.1 years, ranging from 39 to 78 years. The maximum diameter of the tumor was 2-12 cm. All cases had no symptoms, and were accidentally discovered, 3 cases underwent partial renal resection, 10 cases underwent radical renal resection, 9 cases were located in the left kidney, and 4 cases were located in the right kidney. Most of the cases showed the classical morphological changes, with 11 cases of nuclear grading [World Health Organization (WHO)/International Society of Urological Pathology (ISUP) grading system] being G2 and 2 cases being G3. There were 6 cases of stage PT1a, 3 cases of PT1b, 2 cases of PT2a, and 1 case of PT2b and 1 case of PT3a. The positive rates of immunohistochemical staining were: vimentin, AE1/AE3, α-methylacyl-CoA racemase (αMACR) and cytokeratin (CK) 8/18, 100% (13/13); CK7, 92.3% (12/13); epithelial membrane antigen (EMA), 92.3% (12/13); CK20, 46.2% (6/13); CD10, 30.8% (4/13); synaptophysin (Syn), 7.7% (1/13); chromogranin A (CgA), CD57, WT1 and Ki-67, 0 (0/13), and fluorescence in situ hybridization showed that no trisomy of chromosomes 7 and 17 were observed in any of the cases. The follow-up period was 6 months to 7 years and 6 months, 2 cases died after lung metastasis (one with ISUP/WHO grade G3, one with necrosis), and the remaining 11 cases had no recurrence and metastasis. CONCLUSION MTSCC is a unique type of low-grade malignancy kidney tumor, occurs predominantly in females, widely distributed in age, the current treatment method is surgical resection, and cases with necrosis and high-grade morphology are prone to recurrence and metastasis, although most cases have a good prognosis, but they still need close follow-up after surgery.
Collapse
Affiliation(s)
- Q Shen
- Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China
| | - Y X Liu
- Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China
| | - Q He
- Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China
| |
Collapse
|
14
|
Yu EYW, Liu YX, Chen YT, Tang QY, Mehrkanoon S, Wang SZ, Li WC, Zeegers MP, Wesselius A. The effects of the interaction of genetic predisposition with lifestyle factors on bladder cancer risk. BJU Int 2023; 131:443-451. [PMID: 36053730 DOI: 10.1111/bju.15880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVES To investigate the association of polygenic risk score (PRS) and bladder cancer (BC) risk and whether this PRS can be offset by a healthy lifestyle. METHODS Individuals with BC (n = 563) and non-BC controls (n = 483 957) were identified in the UK Biobank, and adjusted Cox regression models were used. A PRS was constructed based on 34 genetic variants associated with BC development, while a healthy lifestyle score (HLS) was constructed based on three lifestyle factors (i.e., smoking, physical activity, and diet). RESULTS Overall, a negative interaction was observed between the PRS and the HLS (P = 0.02). A 7% higher and 28% lower BC risk per 1-standard deviation (SD) increment in PRS and HLS were observed, respectively. A simultaneous increment of 1 SD in both HLS and PRS was associated with a 6% lower BC risk. In addition, individuals with a high genetic risk and an unfavourable lifestyle showed an increased BC risk compared to individuals with low genetic risk and a favourable lifestyle (hazard ratio 1.55, 95% confidence interval 1.16-1.91; P for trend <0.001). Furthermore, population-attributable fraction (PAF) analysis showed that 12%-15% of the BC cases might have been prevented if individuals had adhered to a healthy lifestyle. CONCLUSION This large-scale cohort study shows that a genetic predisposition combined with unhealthy behaviours have a joint negative effect on the risk of developing BC. Behavioural lifestyle changes should be encouraged for people through comprehensive, multifactorial approaches, although high-risk individuals may be selected based on genetic risk.
Collapse
Affiliation(s)
- Evan Yi-Wen Yu
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology & Biostatistics, School of Public Health, Southeast University, Nanjing, China
- Department of Epidemiology, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands
| | - Yu-Xiang Liu
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology & Biostatistics, School of Public Health, Southeast University, Nanjing, China
| | - Ya-Ting Chen
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology & Biostatistics, School of Public Health, Southeast University, Nanjing, China
| | - Qiu-Yi Tang
- Medical School of Southeast University, Nanjing, China
| | - Siamak Mehrkanoon
- Department of Data Science and Knowledge Engineering, Maastricht University, Maastricht, The Netherlands
| | - Shi-Zhi Wang
- Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China
| | - Wen-Chao Li
- Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, China
| | - Maurice P Zeegers
- Department of Epidemiology, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands
| | - Anke Wesselius
- Department of Epidemiology, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands
| |
Collapse
|
15
|
Li CY, He QQ, Li XL, Yuan J, Zhuang DY, Zhou P, Yue T, Liu YX, Shao CX, Xu J. [A retrospective comparative study between robotic thyroidectomy through transoral vestibular approach and bilateral breast-axillary approach]. Zhonghua Wai Ke Za Zhi 2023; 61:227-231. [PMID: 36650969 DOI: 10.3760/cma.j.cn112139-20220810-00348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Objective: To compare the surgical outcome of robotic thyroidectomy through transoral approach and the bilateral breast-axillary approach. Methods: Retrospective analysis was made on the clinical data of patients who performed transoral robotic thyroidectomy (TORT group) or bilateral breast-axillary approach (BABA group) in the Department of Thyroid and Breast Surgery, the 960th Hospital of People's Liberation Army from July 2020 to May 2022. Both groups received lobectomy with lymph node dissection of the central region. A total of 100 cases were included in the study, including 48 cases in the TORT group and 52 cases in the BABA group. The propensity score matching method was used for 1∶1 matching of patients between the 2 groups, with a match tolerance of 0.03. There were 31 patients in each group successfully matched. In the TORT group, there were 5 males and 26 females, aged (33.2±7.9) years (range: 21 to 53 years). While there were 4 males and 27 females in the BABA group, aged (34.6±9.2) years (range: 19 to 58 years). The t test, Mann-Whitney U test, χ2 test or Fisher exact test were used to compare the clinical efficacy between the two groups. Results: All the patients successfully completed robotic thyroid surgery without conversion to open surgery. Compared with BABA group, the TORT group had longer operation time ((211.3±57.2) minutes vs. (126.2±37.8) minutes, t=6.915, P<0.01), shorter drainage tube retention time ((5.4±1.0) days vs. (6.4±1.2) days, t=-3.544, P=0.001), shorter total hospital stay ((6.6±1.2) days vs. (7.4±1.3) days, t=-2.353, P=0.022), and higher cosmetic score (9.46±0.25 vs. 9.27±0.26, t=2.925, P=0.005). There was no significant difference between the two groups in the number of lymph nodes dissection, metastasis in the central compartment, and the incidence of postoperative complications (all P>0.05). Conclusions: Compared with the bilateral breast-axillary approach, the transoral vestibular approach of robotic thyroidectomy is also safe and effective. It shows similar surgical results to the bilateral breast-axillary approach in strictly selected patients, but the postoperative recovery speed is much faster, and the hospital stay is shorter. Transoral robotic thyroidectomy is a more recommended surgical method for patients with high aesthetic demand.
Collapse
Affiliation(s)
- C Y Li
- Department of Thyroid and Breast Surgery, the 960th Hospital of People's Liberation Army, Jinan 250031, China
| | - Q Q He
- Department of Thyroid and Breast Surgery, the 960th Hospital of People's Liberation Army, Jinan 250031, China
| | - X L Li
- Department of Thyroid and Breast Surgery, the 960th Hospital of People's Liberation Army, Jinan 250031, China
| | - J Yuan
- Department of Information, the 960th Hospital of People's Liberation Army, Jinan 250031, China
| | - D Y Zhuang
- Department of Thyroid and Breast Surgery, the 960th Hospital of People's Liberation Army, Jinan 250031, China
| | - P Zhou
- Department of Thyroid and Breast Surgery, the 960th Hospital of People's Liberation Army, Jinan 250031, China
| | - T Yue
- Department of Thyroid and Breast Surgery, the 960th Hospital of People's Liberation Army, Jinan 250031, China
| | - Y X Liu
- Department of Thyroid and Breast Surgery, the 960th Hospital of People's Liberation Army, Jinan 250031, China
| | - C X Shao
- Department of Thyroid and Breast Surgery, the 960th Hospital of People's Liberation Army, Jinan 250031, China
| | - J Xu
- Department of Thyroid and Breast Surgery, the 960th Hospital of People's Liberation Army, Jinan 250031, China
| |
Collapse
|
16
|
Zhang H, Zhang GY, Su WC, Chen YT, Liu YF, Wei D, Zhang YX, Tang QY, Liu YX, Wang SZ, Li WC, Wesselius A, Zeegers MP, Zhang ZY, Gu YH, Tao WA, Yu EYW. High Throughput Isolation and Data Independent Acquisition Mass Spectrometry (DIA-MS) of Urinary Extracellular Vesicles to Improve Prostate Cancer Diagnosis. Molecules 2022; 27:molecules27238155. [PMID: 36500247 PMCID: PMC9737666 DOI: 10.3390/molecules27238155] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/22/2022] [Revised: 11/17/2022] [Accepted: 11/19/2022] [Indexed: 11/25/2022]
Abstract
Proteomic profiling of extracellular vesicles (EVs) represents a promising approach for early detection and therapeutic monitoring of diseases such as cancer. The focus of this study was to apply robust EV isolation and subsequent data-independent acquisition mass spectrometry (DIA-MS) for urinary EV proteomics of prostate cancer and prostate inflammation patients. Urinary EVs were isolated by functionalized magnetic beads through chemical affinity on an automatic station, and EV proteins were analyzed by integrating three library-base analyses (Direct-DIA, GPF-DIA, and Fractionated DDA-base DIA) to improve the coverage and quantitation. We assessed the levels of urinary EV-associated proteins based on 40 samples consisting of 20 cases and 20 controls, where 18 EV proteins were identified to be differentiated in prostate cancer outcome, of which three (i.e., SERPINA3, LRG1, and SCGB3A1) were shown to be consistently upregulated. We also observed 6 out of the 18 (33%) EV proteins that had been developed as drug targets, while some of them showed protein-protein interactions. Moreover, the potential mechanistic pathways of 18 significantly different EV proteins were enriched in metabolic, immune, and inflammatory activities. These results showed consistency in an independent cohort with 20 participants. Using a random forest algorithm for classification assessment, including the identified EV proteins, we found that SERPINA3, LRG1, or SCGB3A1 add predictable value in addition to age, prostate size, body mass index (BMI), and prostate-specific antigen (PSA). In summary, the current study demonstrates a translational workflow to identify EV proteins as molecular markers to improve the clinical diagnosis of prostate cancer.
Collapse
Affiliation(s)
- Hao Zhang
- State Key Laboratory of Bioelectronics, National Demonstration Center for Experimental Biomedical Engineering Education, Southeast University, Nanjing 210096, China
- EVLiXiR Biotech, Nanjing 210032, China
| | - Gui-Yuan Zhang
- State Key Laboratory of Bioelectronics, National Demonstration Center for Experimental Biomedical Engineering Education, Southeast University, Nanjing 210096, China
- EVLiXiR Biotech, Nanjing 210032, China
| | - Wei-Chao Su
- Department of Colorectal Tumor Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China
- Department of Mental Health Research, Xiamen Xianyue Hospital, Xiamen 361012, China
| | - Ya-Ting Chen
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology & Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China
| | - Yu-Feng Liu
- State Key Laboratory of Bioelectronics, National Demonstration Center for Experimental Biomedical Engineering Education, Southeast University, Nanjing 210096, China
- EVLiXiR Biotech, Nanjing 210032, China
- Bell Mountain Molecular MedTech Institute, Nanjing 210032, China
| | - Dong Wei
- State Key Laboratory of Bioelectronics, National Demonstration Center for Experimental Biomedical Engineering Education, Southeast University, Nanjing 210096, China
- Bell Mountain Molecular MedTech Institute, Nanjing 210032, China
| | - Yan-Xi Zhang
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology & Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China
| | - Qiu-Yi Tang
- Medical School of Southeast University, Nanjing 210009, China
| | - Yu-Xiang Liu
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology & Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China
| | - Shi-Zhi Wang
- Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China
| | - Wen-Chao Li
- Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing 210009, China
| | - Anke Wesselius
- Department of Epidemiology, CAPHRI Care and Public Health Research Institute, Maastricht University, 6229ER Maastricht, The Netherlands
- School of Nutrition and Translational Research in Metabolism, Maastricht University, 6229ER Maastricht, The Netherlands
| | - Maurice P. Zeegers
- Department of Epidemiology, CAPHRI Care and Public Health Research Institute, Maastricht University, 6229ER Maastricht, The Netherlands
- School of Nutrition and Translational Research in Metabolism, Maastricht University, 6229ER Maastricht, The Netherlands
| | - Zi-Yu Zhang
- Department of Pathology, Jiangxi Maternal & Child Health Hospital, Nanchang 330006, China
| | - Yan-Hong Gu
- Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China
| | - W. Andy Tao
- Departments of Chemistry and Biochemistry, Purdue University, West Lafayette, IN 47907, USA
- Correspondence: (W.A.T.); (E.Y.-W.Y.)
| | - Evan Yi-Wen Yu
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology & Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China
- Department of Epidemiology, CAPHRI Care and Public Health Research Institute, Maastricht University, 6229ER Maastricht, The Netherlands
- Correspondence: (W.A.T.); (E.Y.-W.Y.)
| |
Collapse
|
17
|
Tao JH, Liu YX, Ming MX, Lu GP, Zeng M, Zhang XB, Wang ZL. [Severe case of COVID-19 in a child]. Zhonghua Er Ke Za Zhi 2022; 60:1212-1214. [PMID: 36319161 DOI: 10.3760/cma.j.cn112140-20220604-00515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Affiliation(s)
- J H Tao
- Pediatric Intensive Care Unit, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China
| | - Y X Liu
- Pediatric Intensive Care Unit, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China
| | - M X Ming
- Pediatric Intensive Care Unit, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China
| | - G P Lu
- Pediatric Intensive Care Unit, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China
| | - M Zeng
- Department of Infectious Diseases, Children's Hospital of Fudan University National Children's Medical Center, Shanghai 201102, China
| | - X B Zhang
- Department of Respiratory Medicine, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China
| | - Z L Wang
- Department of Infectious Diseases, Children's Hospital of Fudan University National Children's Medical Center, Shanghai 201102, China
| |
Collapse
|
18
|
Liu YX, Zheng ZG. [Non-pharmacological prevention and treatment of delirium in the intensive care unit]. Zhonghua Jie He He Hu Xi Za Zhi 2022; 45:851-854. [PMID: 36097921 DOI: 10.3760/cma.j.cn112147-20220527-00457] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Delirium is an acute brain dysfunction that is a common and difficult-to-eliminate problem in the ICU. It is an important factor leading to prolonged hospital stay, increased treatment costs, and long-term cognitive impairment. Nonetheless, compared with the treatment of respiratory failure and its primary disease, the prevention and treatment measurements of delirium have not received enough attention, and its management strategies are still controversial. Evidence-based medicine currently does not support pharmacological approaches to preventing or treating delirium. Instead, it adopts a combination of multiple nonpharmacological methods to manage delirium in ICU patients through standardized evaluation and monitoring under the guidance of doctors and the cooperation of patients and their families.
Collapse
Affiliation(s)
- Y X Liu
- Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health (National Clinical Research Center for Respiratory Diseases, State Key Lab for Respiratory Diseases), Guangzhou 510120, China
| | - Z G Zheng
- Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health (National Clinical Research Center for Respiratory Diseases, State Key Lab for Respiratory Diseases), Guangzhou 510120, China
| |
Collapse
|
19
|
Yu EYW, Zhang H, Fu Y, Chen YT, Tang QY, Liu YX, Zhang YX, Wang SZ, Wesselius A, Li WC, Zeegers MP, Xu B. Integrative Multi-Omics Analysis for the Determination of Non-Muscle Invasive vs. Muscle Invasive Bladder Cancer: A Pilot Study. Curr Oncol 2022; 29:5442-5456. [PMID: 36005168 PMCID: PMC9406560 DOI: 10.3390/curroncol29080430] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/01/2022] [Revised: 07/23/2022] [Accepted: 07/25/2022] [Indexed: 12/28/2022]
Abstract
Objectives: The molecular landscape of non-muscle-invasive (NMIBC) and muscle-invasive (MIBC) bladder cancer based on molecular characteristics is essential but poorly understood. In this pilot study we aimed to identify a multi-omics signature that can distinguish MIBC from NMIBC. Such a signature can assist in finding potential mechanistic biomarkers and druggable targets. Methods: Patients diagnosed with NMIBC (n = 15) and MIBC (n = 11) were recruited at a tertiary-care hospital in Nanjing from 1 April 2021, and 31 July 2021. Blood, urine and stool samples per participant were collected, in which the serum metabolome, urine metabolome, gut microbiome, and serum extracellular vesicles (EV) proteome were quantified. The differences of the global profiles and individual omics measure between NMIBC vs. MIBC were assessed by permutational multivariate analysis and the Mann–Whitney test, respectively. Logistic regression analysis was used to assess the association of each identified analyte with NMIBC vs. MIBC, and the Spearman correlation was used to investigate the correlations between identified analytes, where both were adjusted for age, sex and smoking status. Results: Among 3168 multi-omics measures that passed the quality control, 159 were identified to be differentiated in NMIBC vs. MIBC. Of these, 46 analytes were associated with bladder cancer progression. In addition, the global profiles showed significantly different urine metabolome (p = 0.029), gut microbiome (p = 0.036), and serum EV (extracellular vesicles) proteome (p = 0.039) but not serum metabolome (p = 0.059). We also observed 17 (35%) analytes that had been developed as drug targets. Multiple interactions were obtained between the identified analytes, whereas for the majority (61%), the number of interactions was at 11–20. Moreover, unconjugated bilirubin (p = 0.009) and white blood cell count (p = 0.006) were also shown to be different in NMIBC and MIBC, and associated with 11 identified omics analytes. Conclusions: The pilot study has shown promising to monitor the progression of bladder cancer by integrating multi-omics data and deserves further investigations.
Collapse
Affiliation(s)
- Evan Yi-Wen Yu
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology & Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China; (Y.-T.C.); (Y.-X.L.); (Y.-X.Z.)
- Department of Epidemiology, CAPHRI Care and Public Health Research Institute, Maastricht University, 6229 ER Maastricht, The Netherlands; (A.W.); (M.P.Z.)
- Correspondence: (E.Y.-W.Y.); (H.Z.)
| | - Hao Zhang
- State Key Laboratory of Bioelectronics, National Demonstration Center for Experimental Biomedical Engineering Education, Southeast University, Nanjing 210096, China
- Nanjing EVLiXiR Biotechnology Co., Ltd., Nanjing 210032, China
- Correspondence: (E.Y.-W.Y.); (H.Z.)
| | - Yuanqing Fu
- Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou 310024, China;
- Westlake Intelligent Biomarker Discovery Laboratory, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou 310024, China
- Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou 310024, China
| | - Ya-Ting Chen
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology & Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China; (Y.-T.C.); (Y.-X.L.); (Y.-X.Z.)
| | - Qiu-Yi Tang
- Medical School of Southeast University, Nanjing 210009, China;
| | - Yu-Xiang Liu
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology & Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China; (Y.-T.C.); (Y.-X.L.); (Y.-X.Z.)
| | - Yan-Xi Zhang
- Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology & Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China; (Y.-T.C.); (Y.-X.L.); (Y.-X.Z.)
| | - Shi-Zhi Wang
- Key Laboratory of Environmental Medicine Engineering, School of Public Health, Southeast University, Ministry of Education, Nanjing 210009, China;
| | - Anke Wesselius
- Department of Epidemiology, CAPHRI Care and Public Health Research Institute, Maastricht University, 6229 ER Maastricht, The Netherlands; (A.W.); (M.P.Z.)
- School of Nutrition and Translational Research in Metabolism, Maastricht University, 6229 ER Maastricht, The Netherlands
| | - Wen-Chao Li
- Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing 210009, China; (W.-C.L.); (B.X.)
| | - Maurice P. Zeegers
- Department of Epidemiology, CAPHRI Care and Public Health Research Institute, Maastricht University, 6229 ER Maastricht, The Netherlands; (A.W.); (M.P.Z.)
- School of Nutrition and Translational Research in Metabolism, Maastricht University, 6229 ER Maastricht, The Netherlands
| | - Bin Xu
- Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing 210009, China; (W.-C.L.); (B.X.)
| |
Collapse
|
20
|
Li MM, Yuan DF, Liu YX, Liu YB, Wang B. [Meta analysis on mumps virus seroprevalence and evaluation of immunization effect in Chinese healthy population]. Zhonghua Yu Fang Yi Xue Za Zhi 2022; 56:994-1003. [PMID: 35899355 DOI: 10.3760/cma.j.cn112150-20220402-00313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objective: To systematically analyze the IgG seroprevalence of mumps virus (MuV) in Chinese healthy population, and evaluate the immune effect based on the immunization strategy and the incidence of mumps in China. Methods: The databases of Wanfang data knowledge service platform, China National Knowledge Infrastructure, SinoMed, PubMed, and Web of Science were searched to retrieve literature about the level of MuV IgG antibody in Chinese healthy population from January 1, 2000, to March 31, 2022. The quality of eligible papers was appraised by using the cross-sectional study evaluation tool from Joanna Briggs Institute. Data analysis, including the stratified analysis of the IgG seroprevalence in different generations, regions, gender, immunization status, and age groups, was performed using R 4.1.2 and Stata 16.0. Results: A total of 69 papers (66 in Chinese and 3 in English) were included, involving 97 034 people in 26 administrative regions across China. The results showed that the MuV IgG seroprevalence in Chinese healthy population was 74.87% (95%CI: 71.41%-78.17%) and increased over time according to the cumulative Meta-analysis. The geometric mean concentration of antibody was 177.83 U/ml. The subgroup analysis showed that the positive rate of MuV IgG antibody increased with the age and vaccination doses. The positive rate of antibody in children aged from 0 to 17 months was only 32.42% (95%CI: 25.96%-38.88%). The highest positive rate was reported in North China, about 81.45% (95%CI: 75.76%-87.14%). In addition, the positive rate of MuV IgG antibody in urban population was higher than that in rural population (P<0.01) and the positive rate of MuV IgG antibody in women was higher than that in men (P<0.01). Conclusion: Since the vaccine was included in the expanded immunization program, the positive rate of mumps antibody in China has increased, and the antibody level varies in different regions and populations. It is still necessary to improve the MuV antibody level in Chinese healthy population, so as to better prevent and control the mumps epidemic in the future.
Collapse
Affiliation(s)
- M M Li
- Department of Epidemiology and Health Statistics, Southeast University School of Public Health, Nanjing 210009, China
| | - D F Yuan
- Department of Epidemiology and Health Statistics, Southeast University School of Public Health, Nanjing 210009, China
| | - Y X Liu
- Department of Epidemiology and Health Statistics, Southeast University School of Public Health, Nanjing 210009, China
| | - Y B Liu
- Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China
| | - Bei Wang
- Department of Epidemiology and Health Statistics, Southeast University School of Public Health, Nanjing 210009, China
| |
Collapse
|
21
|
Zeng WL, Liang JE, Liu YX, Wang Y. [Functional characteristics of YAP-positive hepatocytes expression in an early stage of NASH with transcriptome sequence analysis]. Zhonghua Gan Zang Bing Za Zhi 2022; 30:649-655. [PMID: 36038328 DOI: 10.3760/cma.j.cn501113-20200702-00364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objective: To analyze and compare the differentially expressed genes (DEGs) of Yes-associated protein (YAP)-positive and negative hepatocytes and further understand the preliminary functional characteristics of YAP-positive hepatocytes in an early mouse model of nonalcoholic steatohepatitis (NASH) with transcriptome sequence (RNA-Seq). Methods: C57BL/6 mice were fed with methionine-choline deficiency (MCD) diet for 2 weeks to establish an early NASH model, and the control group was fed with normal diet. Liver tissue was stained with hematoxylin-eosin (HE) and Sirius red, and the pathological score was recorded. The expression of YAP and P-YAP were determined by immunohistochemistry (IHC) in liver tissues. Primary hepatocytes with viability greater than 90% were isolated and purified by collagenase perfusion combined with Percoll density gradient centrifugation. YAP-positive and negative hepatocytes were assessed by YAP antibody, flow cytometry and RNA-Seq analyses. Sequencing results were screened by GO, KEGG and interaction network analysis methods. RT-PCR was used to verify the expression levels of YAP and some DEGs in liver tissue model group. Two samples mean was compared by independent samples t-test. Results: Compared with the control group, the HE-stained liver tissue of MCD-induced mice at 2 weeks showed steatosis (pathological score 1.07±0.21), accompanied by lobular inflammation (pathological score 1.13±0.32) and ballooned hepatocyte (pathological score 0.80) ±0.20). Sirius red staining showed non-significant liver fibrosis (pathological score 0.40±0.40). IHC showed partial YAP-positive hepatocytes expression in an early stage of NASH. RNA-Seq analysis showed that clean reads of YAP-positive and negative hepatocytes were 49 310 604 and 5 4820 036, respectively. Compared with YAP-negative hepatocytes, YAP-positive hepatocytes had differential expression of 5 565 genes, including 1 662 up-regulated genes and 3 903 down-regulated genes. GO analysis of up-regulated genes showed that the metabolic processes related to mitochondrial functions, such as purine nucleoside triphosphate and nucleoside triphosphate were significantly enriched in biological processes (BP), while down-regulated gene analysis showed that olfactory-related receptor were significantly enriched in BP. KEGG analysis showed that DEGs were enriched in 292 pathways, and oxidative phosphorylation (OXPHOS) pathway was significantly enriched in signaling pathway. RT-PCR validated that inflammatory factors (interleukin-1β, interleukin-6), YAP and its target genes (Cyr61, Ankrd1), and Cox5b and Sdhc genes were significantly up-regulated in the OXPHOS pathway, which was consistent with the sequencing results. In addition, eight key genes with interaction network analysis were predicted. Conclusion: Changes in hepatocyte metabolic levels may be associated with increased YAP activity in an early stage of NASH.
Collapse
Affiliation(s)
- W L Zeng
- Southern Medical University School of Pharmaceutical Science, Southern Medical University Biomedical Research Center, Guangzhou 510515, China
| | - J E Liang
- Southern Medical University School of Pharmaceutical Science, Southern Medical University Biomedical Research Center, Guangzhou 510515, China
| | - Y X Liu
- Southern Medical University School of Pharmaceutical Science, Southern Medical University Biomedical Research Center, Guangzhou 510515, China
| | - Y Wang
- Southern Medical University School of Pharmaceutical Science, Southern Medical University Biomedical Research Center, Guangzhou 510515, China
| |
Collapse
|
22
|
Wang ZM, Liu Q, Liu YX, Chen YJ, Zhou Q, Deng XL, Zhang XD, Xu BH, Zhu YQ, Gao CZ, Yin L, Xie H, Fei W, Zhou J, Yuan CQ, He XN, Wang X, Chen LL. [Consensus of experts on the oral health management and medical risk prevention for the patients with chronic airway diseases (2022 edition)]. Zhonghua Kou Qiang Yi Xue Za Zhi 2022; 57:455-461. [PMID: 35484667 DOI: 10.3760/cma.j.cn112144-20220228-00081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Today, there is greater awareness on the association between oral diseases and respiration diseases after the outbreak of COVID-19. However, confusion regarding the oral health management and medical risk prevention for patients with chronic airway diseases has been remained among dental clinicians. Therefore, the dental experts of the Fifth General Dentistry Special Committee, Chinese Stomatological Association, combined with the experts of respiratory and critical care medicine, undertook the formation of consensus on the oral health management of patients with chronic airway diseases in order to help dental clinicians to evaluate medical risks and make better treatment decision in clinical practice. In the present consensus report, the relationship of oral diseases and chronic airway diseases, the oral health management and the treatment recommendations of patients with chronic airway diseases are provided.
Collapse
Affiliation(s)
- Z M Wang
- Department of Stomatology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China
| | - Q Liu
- Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Y X Liu
- Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China
| | - Y J Chen
- Department of General Dentistry & Emergency, School of Stomatology, The Fourth Military Medical University & State Key Laboratory of Military Stomatology & National Clinical Research Center for Oral Diseases & Shaanxi International Joint Research Center for Oral Diseases, Xi'an 710032, China
| | - Q Zhou
- Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - X L Deng
- Department of Geriatric Dentistry, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
| | - X D Zhang
- Department of Stomatology, General Hospital of Northern Theater Command, Shenyang 110016, China
| | - B H Xu
- Department of Stomatology, China-Japan Friendship Hospital, Beijing 100029, China
| | - Y Q Zhu
- Department of General Dentistry, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine & College of Stomatology, Shanghai Jiao Tong University & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Shanghai Key Laboratory of Stomatology, Shanghai 200011, China
| | - C Z Gao
- Department of Stomatology, Peking University People's Hospital, Beijing 100044, China
| | - L Yin
- Department of Stomatology, The First Affiliated Hospital With Nanjing Medical University, Nanjing 210029, China
| | - H Xie
- Department of Stomatology, The People's Hospital of Liaoning Province, Shenyang 110016, China
| | - W Fei
- Department of Stomatology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu 610072, China
| | - J Zhou
- Department of VIP Dental Service, Capital Medical University School of Stomatology, Beijing 100050, China
| | - C Q Yuan
- Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao 266003, China
| | - X N He
- Department of Stomatology, The Second Affiliated Hospital of Hainan Medical University, Haikou 570100, China
| | - X Wang
- Department of Stomatology, Peking University Third Hospital, Beijing 100191, China
| | - L L Chen
- Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| |
Collapse
|
23
|
Wu SJ, Liu XH, Wu W, Qian M, Li L, Zhang L, Yang HH, Guan M, Cao J, Wang YN, Ruan GR, Niu N, Liu YX. [Tocilizumab therapy for immune checkpoint inhibitor associated myocarditis: a case report]. Zhonghua Xin Xue Guan Bing Za Zhi 2022; 50:397-400. [PMID: 35399037 DOI: 10.3760/cma.j.cn112148-20210511-00412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
- S J Wu
- Department of Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - X H Liu
- Department of Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - W Wu
- Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - M Qian
- Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - L Li
- Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - L Zhang
- Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - H H Yang
- Department of Rheumatology and Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - M Guan
- Department of Oncology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - J Cao
- Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Y N Wang
- Department of Radiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - G R Ruan
- Department of Infectious Disease, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - N Niu
- Department of Nuclear Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Y X Liu
- Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| |
Collapse
|
24
|
Liu YX, Pan YQ, Yang L, Ahmad S, Zhou XB. Stover return and nitrogen application affect soil organic carbon and nitrogen in a double-season maize field. Plant Biol (Stuttg) 2022; 24:387-395. [PMID: 34866298 DOI: 10.1111/plb.13370] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/13/2021] [Accepted: 11/07/2021] [Indexed: 06/13/2023]
Abstract
Cultivation techniques have an important influence on grain yield of maize. This experiment investigated the effect of stover return (SR) and different nitrogen (N) application rate on soil organic carbon (SOC) composition, soil nutrient and maize yield. Different nitrogen application rate 100 (N100), 150 (N150), 200 (N200), 250 (N250) or 300 (N300) kg ha-1 applied to the maize field with stover return and without stover return traditional planting (TP) method. Nitrogen application rate and stover return affected the SOC, labile organic carbon (LOC), microbial biomass (MBC), NO3 - -N, NH4 + -N and maize yield. Soil N, soil carbon content and maize yield of SR were all higher than TP. The SOC content of SR and TP were 9.67 and 9.19 g kg-1 , respectively. Nitrogen application was significantly and positively correlated with soil MBC, LOC, SOC, NO3 - -N, NH4 + -N and yield. The maximum values of SOC composition, soil nutrients and maize yield were reached at SR with 250 kg ha-1 . Stover return with application of N 250 kg ha-1 significantly increased the growth attribute and maize yield in subtropical region compared with traditional planting.
Collapse
Affiliation(s)
- Y X Liu
- Guangxi Colleges and Universities Key Laboratory of Crop Cultivation and Tillage, Agricultural College of Guangxi University, Nanning, 530004, China
| | - Y Q Pan
- Guangxi Colleges and Universities Key Laboratory of Crop Cultivation and Tillage, Agricultural College of Guangxi University, Nanning, 530004, China
| | - L Yang
- Guangxi Colleges and Universities Key Laboratory of Crop Cultivation and Tillage, Agricultural College of Guangxi University, Nanning, 530004, China
| | - S Ahmad
- Guangxi Colleges and Universities Key Laboratory of Crop Cultivation and Tillage, Agricultural College of Guangxi University, Nanning, 530004, China
| | - X B Zhou
- Guangxi Colleges and Universities Key Laboratory of Crop Cultivation and Tillage, Agricultural College of Guangxi University, Nanning, 530004, China
| |
Collapse
|
25
|
Zeng ZY, Huang PY, Du JY, Liu YX, Guo SG, Zeng LS, Zhang CC, Li Y. Effect of Agkistrodon halys antivenom in patients bit by green pit viper and the prognostic role of the disease - a retrospective cohort study. Clin Toxicol (Phila) 2022; 60:808-817. [PMID: 35225104 DOI: 10.1080/15563650.2022.2041200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND AND AIMS In Mainland China and Hong Kong, health authorities utilize Agkistrodon halys antivenom in the treatment of patients who sustained bites from green pit vipers. However, the treatment benefit of Agkistrodon halys antivenom among such patients is still controversial. The purpose of this study is to evaluate the coagulation parameters normalization time of Agkistrodon halys antivenom in patients who sustained green pit viper bites and explore independent risk factors of patient prognosis. METHODS Data were extracted from the Donghua Hospital Information System. Comparison of the two groups of patients - who used antivenom (GPUA) and who did not use antivenom (GPNUA) were performed using stratified analysis, univariate and multivariate ordered logistic regression models to evaluate the coagulation parameters normalization time. Univariate and multivariate ordered logistic regression models were used to explore independent risk factors of patient prognosis. RESULTS Between the GPUA and GPNUA groups, there is no significant difference in the coagulation parameters normalization time with the treatment of Agkistrodon halys antivenom. GPNUA consumed more cryoprecipitate and platelets and had a lower cost. The patient's severity of the bite, first coagulation profile, and dosages of fresh frozen plasma, platelet, and red cell suspension was found to be risk factors for the normalization time of coagulation parameters. CONCLUSIONS The therapeutic effect of Agkistrodon halys antivenom in green pit vipers bite patients is not quite satisfying. In addition, more attention should be paid to the first coagulation profile, blood clotting factors indices, platelet count (PLT), and hemoglobin when treating such patients.
Collapse
Affiliation(s)
- Zhong-Yi Zeng
- Emergency Department, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, PR China
| | - Pei-Ying Huang
- The Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, PR China.,Emergency Department, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, PR China
| | - Jia-Yu Du
- Emergency Department, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, PR China
| | - Yu-Xiang Liu
- Emergency Department, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, PR China
| | - Shi-Gong Guo
- Department of Rehabilitation Medicine, Southmead Hospital, Bristol, UK
| | - Lin-Sheng Zeng
- Emergency Department, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, PR China
| | - Cong-Cong Zhang
- Emergency Department, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, PR China
| | - Yi Li
- Emergency Department, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, PR China
| |
Collapse
|
26
|
Hou WH, Duan XK, Hou WD, Liu YX, Wang JH, Wang XZ, Ma LJ, Shi ZY, Li QM, Jin ML. [Clinicopathological features of very well-differentiated adenocarcinoma of the stomach]. Zhonghua Bing Li Xue Za Zhi 2022; 51:96-102. [PMID: 35152626 DOI: 10.3760/cma.j.cn112151-20210723-00525] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Objective: To investigate the clinicopathological features of very well-differentiated adenocarcinoma (VWDA) of the stomach. Methods: The clinicopathological data of 12 cases of VWDA of the stomach were collected retrospectively at the People's Liberation Army Joint Logistics Support Force 989 Hospital (formerly 152 Hospital), Pingdingshan, China, from January 2013 to May 2021. The histological characteristics and immunophenotypes were observed and analyzed with review of current literature. Results: There were 8 males and 4 females with a median age of 63 years (range 47 to 80 years). The tumor involved in the upper part of the stomach in 6 cases, the middle part in 2 cases, and the lower part in 4 cases. The median diameter of the tumors was 17 mm (range 5-65 mm). The tumor cells were similar to absorbent cells, Paneth cells, foveolar epithelial cells, and goblet cells. The cells were arranged in a single layer, and the nuclei were slightly enlarged and located at the base. The nuclei were fusiform to slightly irregular, with loss of nuclear polarity. Early tubular VWDA was found in 9 cases, and the tumor glands were similar to intestinal metaplasia. In two cases the tumors infiltrated into the submucosa. The lesions in the mucosa and submucosa showed the glands with cystic expansion, bending, branching, spiky and abortive growth pattern. One case of early papillary tubular VWDA was confined to the mucosal layer and composed of foveolar-type epithelial cells. There were two cases of advanced papillary tubular VWDA, which consisted of foveolar-type epithelial, pyloric glands, or mucinous neck cells and were associated with intra-lymphatic cancer embolus and lymph node metastases. Background mucosal atrophy and intestinal metaplasia were observed in all cases. Immunohistochemical staining showed intestinal type VWDA in 1 case, mixed gastrointestinal type VWDA in 9 cases, and gastric type VWDA in 2 cases. The Ki-67 proliferation index of 8 cases limited to the mucosa was 40%-70%, 2 cases of infiltration into the submucosa and 2 cases of advanced carcinoma was 10%-25%. All the tumors showed a wild type of p53 protein expression pattern and negative HER2. Adenocarcinoma or high-grade dysplasia was diagnosed on preoperative biopsy in 5 cases, and chronic atrophic gastritis with intestinal metaplasia in 7 cases. The median follow-up time was 28 months (range 12-72 months). No recurrence was found in the 10 patients with early cancer. Of the two patients with advanced carcinoma, one patient had lung metastases and the other died. Conclusions: Gastric VWDA is a rare low-grade malignancy with structural features of highly differentiated adenocarcinoma and extremely low cytological atypia. The diagnostic value of structural abnormality is significantly greater than cytological atypia. The invasive growth of irregular glands in the deep mucosa and submucosa is reliable evidence for diagnosis. The diagnosis of intramucosal VWDA is challenging and very difficult in some biopsy specimens.
Collapse
Affiliation(s)
- W H Hou
- Department of Pathology, People's Liberation Army Joint Logistics Support Force 989 Hospital (formerly 152 Hospital), Pingdingshan 467099, China
| | - X K Duan
- Department of Gastroenterology, People's Liberation Army Joint Logistics Support Force 989 Hospital (formerly 152 Hospital), Pingdingshan 467099, China
| | - W D Hou
- Department of Endocrinology, Pingdingshan Municipal First People's Hospital, Henan Province, Pingdingshan 467099, China
| | - Y X Liu
- Department of Endocrinology, Pingdingshan Municipal First People's Hospital, Henan Province, Pingdingshan 467099, China
| | - J H Wang
- Department of Endocrinology, Pingdingshan Municipal First People's Hospital, Henan Province, Pingdingshan 467099, China
| | - X Z Wang
- Department of Gastroenterology, People's Liberation Army Joint Logistics Support Force 989 Hospital (formerly 152 Hospital), Pingdingshan 467099, China
| | - L J Ma
- Department of Gastroenterology, People's Liberation Army Joint Logistics Support Force 989 Hospital (formerly 152 Hospital), Pingdingshan 467099, China
| | - Z Y Shi
- Department of Pathology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - Q M Li
- Department of Pathology, People's Liberation Army Joint Logistics Support Force 989 Hospital (formerly 152 Hospital), Pingdingshan 467099, China
| | - M L Jin
- Department of Pathology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| |
Collapse
|
27
|
Wang LC, Liu YX, Dun YJ, Sun XG. Early and mid-term outcomes of modified aortic root repair for acute stanford type A aortic dissection. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Acute Stanford type A aortic dissection (ATAAD) is the most common catastrophic aortic event. Most ATAAD involves the aortic root which has many important anatomical structures such as aortic valve, so the proper treatment of dissected root can ensure a good prognosis for patients. However, there is still no consensus on root management strategies for ATAAD patients with aortic root involvement.
Purpose
This clinical study aimed to evaluate the therapeutic effect of modified aortic root repair in ATAAD.
Methods
From September 2017 to September 2020, Participants with root involvement of ATAAD were recruited who underwent modified aortic root repair as well as some additional procedure such as aortic valve junction suspension plasty based on the aortic sinus tear extent. During this novel procedure, the proximal anastomosis plane was at the level of the sinu-tubular junction and the false lumen below it was retained. We collected and analyzed the perioperative clinical data and follow-up imaging data of patients, and further evaluated the early and mid-term efficacy of this surgical approach.
Results
A total of 79 patients were enrolled, including 59 males and 20 females, the age was (52.4±11.3) years old (28–73 years), the diameter of aortic sinus was (38.6±4.1) mm, and the diameter of sinu-tubular junction was (41.8±4.8) mm. In this group, 75 patients (94.9%) received ascending aorta replacement, total arch replacement and frozen elephant trunk, 2 patients (2.5%) received ascending aorta replacement and hybrid total arch replacement, 2 patients (2.5%) received ascending aorta replacement and partial arch replacement. Cardiopulmonary bypass time was (197.2±58.6) min (118–455 min), blocking time was (132.6±38.9) min (73–323 min), circulatory arrest time was (10.3±7.0) min (0–27 min). There was no perioperative death, no paraplegia, one secondary thoracotomy, five renal failures needing hemodialysis treatment and two cerebral infarctions. Before patients discharged, aortic CTA showed that the residual false lumen in the sinus disappeared. And the diameter of the aortic sinus was (35.5±3.1) mm, the diameter of the junction of the aortic sinus was (30.0±3.0) mm. The patients were followed up for (18±12) months (3–35 months). There was one patient died during follow-up and no further surgical intervention at the root of the aorta. Follow-up aortic CTA showed no residual or new dissection in the aortic sinus and no significant difference in the diameters of aortic sinu-tubular junction (P=0.122) or aortic sinus (P=0.37) between postoperative period and follow-up period. Echocardiography showed that the structure and function of the aortic valve were normal.
Conclusions
The modified aortic root repair for ATAAD is relatively simple, easy to learn and safe in perioperative period. Early and mid-term follow-up image examination showed that the structure of aortic sinus returned to normal. The long-term clinical effect requires close attention.
Funding Acknowledgement
Type of funding sources: None. Modified aortic root repair procedureAortic root diameter change under CTA
Collapse
Affiliation(s)
- L C Wang
- Fuwai Hospital, CAMS and PUMC, Department of Cardiovascular Surgery, Beijing, China
| | - Y X Liu
- Fuwai Hospital, CAMS and PUMC, Department of Cardiovascular Surgery, Beijing, China
| | - Y J Dun
- Fuwai Hospital, CAMS and PUMC, Department of Cardiovascular Surgery, Beijing, China
| | - X G Sun
- Fuwai Hospital, CAMS and PUMC, Department of Cardiovascular Surgery, Beijing, China
| |
Collapse
|
28
|
Ma LL, Liu YX, Guo SP. [Breast secretory carcinoma with predominant papillary morphology: report of a case]. Zhonghua Bing Li Xue Za Zhi 2021; 50:1183-1185. [PMID: 34619877 DOI: 10.3760/cma.j.cn112151-20210323-00225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- L L Ma
- Department of Pathology, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China
| | - Y X Liu
- Department of Pathology, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China
| | - S P Guo
- Department of Pathology, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China
| |
Collapse
|
29
|
Yang X, Chen S, Qi Y, Xu XY, Guan X, Yang YC, Liu YX, Guo YH, Gong WC, Gao YN, Wang XH, Li W, Li LF, Fu K, Zhang HL, Meng B. [Research of prognostic immunophenotypes in 163 patients of diffuse large B-cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi 2021; 42:487-494. [PMID: 34384155 PMCID: PMC8295611 DOI: 10.3760/cma.j.issn.0253-2727.2021.06.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
目的 筛选并分析与弥漫大B细胞淋巴瘤(DLBCL)预后相关的免疫表型,探究其预后价值。 方法 选取天津医科大学肿瘤医院2011年1月至2016年12月收治的163例DLBCL患者,免疫组织化学染色检测DLBCL常见免疫表型,COX模型探索独立于国际预后指数(IPI)影响总生存(OS)与无进展生存(PFS)的免疫表型,并分析其两两联合表达对预后的影响。 结果 多因素分析显示BCL6阴性(PFS:HR=1.652,95% CI 1.030~2.649,P=0.037)、P53阳性(OS:HR=1.842,95% CI 1.008~3.367,P=0.047)、BCL2强阳性(OS:HR=2.102,95%CI 1.249~3.537,P=0.005;PFS:HR=2.126,95% CI 1.312~3.443,P=0.002)是DLBCL中独立于IPI的预后不良因素。亚组分析显示,在年龄≤60岁组患者中BCL6阴性(PFS:HR=2.042,95%CI 1.021~4.081,P=0.043)、P53阳性(OS:HR=3.069,95% CI 1.244~7.569,P=0.015)和BCL2强阳性(OS:HR=2.433,95% CI 1.165~5.082,P=0.018;PFS:HR=3.209,95%CI 1.606~6.410,P=0.001)对预后影响显著;在IPI 0~2分亚组患者中,BCL6阴性(OS:HR=2.467,95%CI 1.322~4.604,P=0.005;PFS:HR=2.248,95%CI 1.275~3.965,P=0.005)和BCL2强阳性(PFS:HR=2.045,95%CI 1.119~3.735,P=0.020)对预后影响显著。BCL6和BCL2强阳性的联合表达与DLBCL的预后相关(P=0.005和P<0.001),BCL6阳性/BCL2非强阳性(86例)预后最好[3年OS率(71.6±4.9)%,3年PFS率(67.0±5.1)%],BCL6阴性/BCL2强阳性(10例)预后最差[3年OS率(20.0±12.6)%,3年PFS率(10.0±9.5)%];BCL6、P53的联合表达与DLBCL的预后差异无统计学意义(P=0.061和P=0.089),但生存曲线显示BCL6阳性/P53阴性的病例(98例)预后较好[3年OS率(70.6±4.7)%,3年PFS率(64.6±4.9)%];BCL2强阳性、P53的联合表达与DLBCL的预后显著相关(P<0.001和P<0.001),BCL2强阳性/P53阳性的病例(5例)预后最差(3年OS率和PFS率均为0);无论BCL6与P53表达如何,BCL2强阳性的病例预后均比非强阳性病例差。 结论 BCL6阴性、P53阳性、BCL2强阳性三种免疫表型单独及联合表达对DLBCL尤其是年龄≤60岁和IPI 0~2分患者的预后预测具有一定价值。
Collapse
Affiliation(s)
- X Yang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - S Chen
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - Y Qi
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - X Y Xu
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - X Guan
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - Y C Yang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - Y X Liu
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - Y H Guo
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - W C Gong
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - Y N Gao
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - X H Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - W Li
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - L F Li
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - K Fu
- Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York, USA
| | - H L Zhang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - B Meng
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| |
Collapse
|
30
|
Xu XC, He S, Zhou YQ, Liu CJ, Liu SQ, Peng W, Liu YX, Wei PP, Bei JX, Luo CL. RNA-binding motif protein RBM47 promotes tumorigenesis in nasopharyngeal carcinoma through multiple pathways. J Genet Genomics 2021; 48:595-605. [PMID: 34274258 DOI: 10.1016/j.jgg.2021.05.006] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2021] [Revised: 04/29/2021] [Accepted: 05/01/2021] [Indexed: 12/13/2022]
Abstract
RNA binding motif proteins (RBMs) have been widely implicated in the tumorigenesis of multiple human cancers but scarcely studied in nasopharyngeal carcinoma (NPC). Here, we compare the mRNA levels of 29 RBMs between 87 NPC and 10 control samples. We find that RBM47 is frequently upregulated in NPC specimens, and its high expression is associated with the poor prognosis of patients with NPC. Biological experiments show that RBM47 plays an oncogenic role in NPC cells. Mechanically, RBM47 binds to the promoter and regulates the transcription of BCAT1, and its overexpression partially rescues the inhibitory effects of RBM47-knockdown on NPC cells. Moreover, transcriptome analysis reveals that RBM47 regulates alternative splicing of pre-mRNA, including those cancer-related, to a large extent in NPC cells. Furthermore, RBM47 binds to hnRNPM and cooperatively regulates multiple splicing events in NPC cells. In addition, we find that knockdown of hnRNPM inhibits proliferation and migration of NPC cells. Our study, taken together, shows that RBM47 promotes the progression of NPC through multiple pathways, acting as a transcriptional factor and a modulator of alternative splicing in cooperation with hnRNPM. Our study also highlights that RBM47 and hnRNPM could be prognostic factors and potential therapeutic targets for NPC.
Collapse
Affiliation(s)
- Xiao-Chen Xu
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, PR China
| | - Shuai He
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, PR China
| | - Ya-Qing Zhou
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, PR China
| | - Chu-Jun Liu
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, PR China
| | - Shu-Qiang Liu
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, PR China
| | - Wan Peng
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, PR China
| | - Yu-Xiang Liu
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, PR China
| | - Pan-Pan Wei
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, PR China
| | - Jin-Xin Bei
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, PR China; Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou 510060, PR China; Department of Medical Oncology, National Cancer Centre of Singapore, Singapore
| | - Chun-Ling Luo
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, PR China.
| |
Collapse
|
31
|
Wu LJ, Li XX, Liu YX, Yang F, Zhou Q, Ren RP, Lyu YK. Optimization of hydrothermal pretreatment conditions for mesophilic and thermophilic anaerobic digestion of high-solid sludge. Bioresour Technol 2021; 321:124454. [PMID: 33285502 DOI: 10.1016/j.biortech.2020.124454] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/30/2020] [Revised: 11/21/2020] [Accepted: 11/23/2020] [Indexed: 06/12/2023]
Abstract
Hydrothermal pretreatment (HTP) conditions were optimized for continuous mesophilic (MAD) and thermophilic (TAD) anaerobic digestion of high-solid sludge (10-11% total solids). COD solubilization increased with prolonged HTP durations, and became not significant after 210 min. According to the methane production rate and energy consumption, the optimal HTP temperature was determined at 160 °C. Regarding continuous operation without HTP, TAD achieved higher methane yield and volatile solids (VS) reduction, at 0.12 L/g VSadded and 23.9%, respectively. After HTP, methane yield and VS reduction in MAD and TAD were increased by 400% and 191% (MAD), 67% and 72% (TAD), respectively. TAD was limited due to the inhibition from about 2800 mg/L of NH4+-N concentration. The methanogenic activity of MAD was enhanced, whereas TAD displayed a reduced value owing to ammonia inhibition. Ultimately, MAD with HTP and TAD without HTP achieved the higher energy balance, 5.25 and 3.27 kJ/g VS, respectively.
Collapse
Affiliation(s)
- Li-Jie Wu
- Key Laboratory of Coal Science and Technology, Ministry of Education and Shanxi Province, Taiyuan University of Technology, Taiyuan 030024, China.
| | - Xiao-Xiao Li
- College of Environmental Science and Engineering, Taiyuan University of Technology, Taiyuan 030024, China
| | - Yu-Xiang Liu
- College of Environmental Science and Engineering, Taiyuan University of Technology, Taiyuan 030024, China
| | - Fan Yang
- Key Laboratory of Coal Science and Technology, Ministry of Education and Shanxi Province, Taiyuan University of Technology, Taiyuan 030024, China
| | - Quan Zhou
- Key Laboratory of Coal Science and Technology, Ministry of Education and Shanxi Province, Taiyuan University of Technology, Taiyuan 030024, China
| | - Rui-Peng Ren
- Key Laboratory of Coal Science and Technology, Ministry of Education and Shanxi Province, Taiyuan University of Technology, Taiyuan 030024, China
| | - Yong-Kang Lyu
- Key Laboratory of Coal Science and Technology, Ministry of Education and Shanxi Province, Taiyuan University of Technology, Taiyuan 030024, China
| |
Collapse
|
32
|
Wu Y, Lu JX, Yan ZZ, Liu YX, Gu WP, Fu XQ, Xu YC, Wu AH, Huang HH, Zong ZY, Jin DZ, Zhao JH, Chen Y, Liu WP, Li WG. [Interpretation of group standard for Clostridioides difficile infection diagnosis]. Zhonghua Liu Xing Bing Xue Za Zhi 2021; 42:64-67. [PMID: 33503698 DOI: 10.3760/cma.j.cn112338-20201026-01272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Clostridioides difficile is a key pathogen of antibiotic related diarrhea and hospital associated infection, causing several outbreaks in Europe and North Americans and resulting in severe disease burden. However, the standardized diagnostic principle and detection specifications in C. difficile infection (CDI) survey are limited in China, and the infection rate and disease burden of CDI in China are unclear. Therefore, National Institute for Communicable Disease Control and Prevention,National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, together with another 11 institutions, draft the group standard entitled "Diagnosis of Clostridium difficile infection (T/CPMA 008-2020)" of Chinese Preventive Medicine Association. Based on the principle of "legality, scientificity, advancement, and feasibility", this standard clarifies risk factors, diagnosis principles, diagnoses and differential diagnoses in order to improve the accuracy of CDI diagnosis in clinical practice, guide the surveillance for CDI, and understand the infection rate and disease burden of CDI in China.
Collapse
Affiliation(s)
- Y Wu
- National Institute for Communicable Disease Control and Prevention, Chines Center for Disease Control and Prevention, Beijing 102206, China
| | - J X Lu
- National Institute for Communicable Disease Control and Prevention, Chines Center for Disease Control and Prevention, Beijing 102206, China
| | - Z Z Yan
- Chinese People' s Liberation Army General Hospital, Beijing 100853, China
| | - Y X Liu
- Chinese People' s Liberation Army General Hospital, Beijing 100853, China
| | - W P Gu
- Yunnan Provincial Center for Disease Control and Prevention, Kunming 650022, China
| | - X Q Fu
- Yunnan Provincial Center for Disease Control and Prevention, Kunming 650022, China
| | - Y C Xu
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730,China
| | - A H Wu
- Xiangya Hospital of Central South University, Changsha 410008, China
| | - H H Huang
- Huashan Hospital, Fudan University, Shanghai 200040, China
| | - Z Y Zong
- West China Hospital, Sichuan University, Chengdu 610041,China
| | - D Z Jin
- Hangzhou Medical College, Hangzhou 310053, China
| | - J H Zhao
- The Second Hospital of Hebei Medical University, Shijiazhuang 050061, China
| | - Y Chen
- Southern Hospital of Southern Medical University, Guangzhou 510515, China
| | - W P Liu
- Inner Mongolia Autonomous Region People' s Hospital, Hohhot 010017, China
| | - W G Li
- Shandong Provincial Hospital, Ji'nan 250021, China
| |
Collapse
|
33
|
Wang W, Zhang XH, Zhu L, Liu YX. Investigation of Allergic Sensitization Pattern in 4,203 Children in Northern China. Int Arch Allergy Immunol 2020; 182:455-458. [PMID: 33296895 DOI: 10.1159/000511976] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2020] [Accepted: 09/29/2020] [Indexed: 11/19/2022] Open
Abstract
OBJECTIVE The objective of this study is to investigate the allergen sensitization pattern among 4,203 children in the Shanxi region of China and to provide guidance for diagnosis and prevention of allergic diseases. METHODS A retrospective analysis was conducted on the allergen-specific immunoglobulin E (sIgE) results of 4,203 children aged 0-12 years from January to December in 2019. SIgE antibodies to 19 allergens in the serum sample were detected by enzyme ALLERGO-SORBENT testing. RESULTS In total, 49.70% (2,089/4,203) of children with allergic diseases were positive for sIgE, and the top 5 allergens were egg white 18.63% (783/4,203), artemisia 14.47% (608/4,203), milk 13.04% (548/4,203), ragweed 8.66% (364/4,203), and poplar/willow/elm 8.52% (358/4,203). Significant differences in the positive rate of food allergens and aeroallergens in different ages were found (p < 0.05). 50.98% (1,065/2,089) patients were sensitive to 2 or more allergens. The high sensitization rate in the >3-year group was significantly higher than the ≤3-year group (p < 0.05). CONCLUSION Egg white and artemisia are the most common allergens in children in northern China. This study provides allergic sensitization pattern of children and clinical epidemiological data in the region.
Collapse
Affiliation(s)
- Wei Wang
- Department of Laboratory Medicine, Shanxi Provincial People's Hospital, Taiyuan, China
| | - Xian-Hui Zhang
- Department of Laboratory Medicine, Children's Hospital of Shanxi Province, Taiyuan, China
| | - Lei Zhu
- Department of Laboratory Medicine, Children's Hospital of Shanxi Province, Taiyuan, China
| | - Yu-Xiang Liu
- First Affiliated Hospital , Shanxi Medical University, Taiyuan, China,
| |
Collapse
|
34
|
Chen L, Liu YX, Zhao CQ. [The developments of cervical gastric-type adenocarcinoma and its spectrum lesions]. Zhonghua Bing Li Xue Za Zhi 2020; 49:861-866. [PMID: 32746562 DOI: 10.3760/cma.j.cn112151-20200225-00140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- L Chen
- Department of Pathology, Tianjin Central Hospital of Gynecology and Obstetrics, Nankai University Affiliated Maternity Hospital, Tianjin Key Laboratory of Human Development and Reproductive Regulation, Tianjin 300100, China
| | - Y X Liu
- Department of Pathology, Tianjin Central Hospital of Gynecology and Obstetrics, Nankai University Affiliated Maternity Hospital, Tianjin Key Laboratory of Human Development and Reproductive Regulation, Tianjin 300100, China
| | - C Q Zhao
- Department of Pathology, Pittsburgh University, Pittsburgh, PA15213, U S A
| |
Collapse
|
35
|
Jiang SW, Gao H, Wu L, Wang GW, Cen FL, Li JX, Feng C, Wen JM, Chen Y, He RL, Qiao K, Wang Y, Liu YX, Wang ZQ. [Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results]. Zhonghua Xin Xue Guan Bing Za Zhi 2020; 48:580-586. [PMID: 32455515 DOI: 10.3760/cma.j.cn112148-20200304-00155] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyse the clinical history, laboratory tests and pathological data of a patient who suffered from novel coronavirus pneumonia(COVID-19) and provide reference for the clinical treatment of similar cases. Methods: Data of clinical manifestation, laboratory examination, bronchoscopy, echocardiography and cardiopulmonary pathological results were retrospectively reviewed in a case of COVID-19 with rapid exacerbation from mild to critical condition. Results: This patient hospitalized at day 9 post 2019 novel coronavirus(2019-nCoV) infection, experienced progressive deterioration from mild to severe at day 12, severe to critical at day 18 and underwent extracorporeal membrane oxygenation(ECMO) and continuous renal replacement therapy(CRRT) as well as heart lung transplantation during day 28-45 post infection, and died at the second day post heart and lung transplantation. The patient had suffered from hypertension for 8 years. At the early stage of the disease, his symptoms were mild and the inflammatory indices increased and the lymphocyte count decreased continuously. The patient's condition exacerbated rapidly with multi-organ infections, and eventually developed pulmonary hemorrhage and consolidation, pulmonary hypertension, right heart failure, malignant ventricular arrhythmias, liver dysfunction, etc. His clinical manifestations could not be improved despite viral RNAs test results became negative. The patient underwent lung and heart transplantation and finally died of multi organ failure at the second day post lung and heart transplantation. Pathological examination indicated massive mucus, dark red secretions and blood clots in bronchus. The pathological changes were mainly diffused pulmonary hemorrhagic injuries and necrosis, fibrosis, small vessel disease with cardiac edema and lymphocyte infiltration. Conclusions: The clinical course of severe COVID-19 can exacerbate rapidly from mild to critical with lung, liver and heart injuries.
Collapse
Affiliation(s)
- S W Jiang
- Department of Cardiology, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - H Gao
- Department of Cardiology, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - L Wu
- Department of Cardiology, Peking University First Hospital, Beijing 100034, China
| | - G W Wang
- Intensive Care Unit, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - F L Cen
- Intensive Care Unit, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - J X Li
- Intensive Care Unit, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - C Feng
- Department of Medical Ultrasonics, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - J M Wen
- Intensive Care Unit, Fuwai Hospital, Chinese Academy of Medical Sciences Shenzhen, Shenzhen 518057, China
| | - Y Chen
- Department of Hemodialysis, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - R L He
- Department of Anesthesia, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - K Qiao
- Department of Cardiothoracic Surgery, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - Y Wang
- Department of Anesthesia, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - Y X Liu
- Administration Office, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - Z Q Wang
- Administration Office, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| |
Collapse
|
36
|
Huang P, Chen S, Yang X, Lei YY, Xu XY, Liu YX, Guo YH, Pan Y, Wang XH, Zhang HL, Fu K, Meng B. [Prognostic evaluation of P53 and BCL2 proteins in MYC/BCL2 double expression DLBCL]. Zhonghua Xue Ye Xue Za Zhi 2020; 40:589-593. [PMID: 32397023 PMCID: PMC7364905 DOI: 10.3760/cma.j.issn.0253-2727.2019.07.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the strong expression (S+) of P53 and BCL2 proteins in MYC/BCL2 double-expression DLBCL (DEL) and whether they can be used for the prognostic evaluation and stratified diagnosis of DELs. Methods: Tissue microarray were made by filed FFPE blocks of 174 DLBCL cases. The translocation of MYC, BCL2 and BCL6 genes were detected by FISH, and the proteins were detected by IHC. Data of clinicopathologic features and follow up of patients were collected and OS (overall survival) and PFS (progression free survival) were analyzed by statistics. Results: Eight double-hit lymphomas (DHLs) were identified in all cases, and 45 DELs were selected from 166 remaining cases, which have no significant difference in OS and PFS compared with non-DEL cases (P=0.668 and P=0.790) . Of 42 DEL-cases with follow up data, 24 cases with P53+ or/and BCL2 (S+) are significantly shorter OS and PFS than others (P=0.003 and P=0.000) , in which the cases with P53+/BCL2 (S+) co-expression were the worst prognosis, and P53/BCL2 co-weaker positive DEL cases even have superior OS and PFS than those non-DELs. Although statistics showed that the cases of P53+ or/and BCL2 (S+) have a lower OS and PFS in total cases (P=0.063 and P=0.024) , it is not the case when the DEL-cases take out from total cases, that is the cases with P53+ or/and BCL2 (S+) are as similar OS and PFS as others in non-DEL group (P=0.590 and P=0.550) . Conclusion: The strong expression of P53 and BCL2 proteins can be used as indicators of stratified diagnosis and poor prognosis of DEL.
Collapse
Affiliation(s)
- P Huang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital Tianjin 300060, China
| | - S Chen
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital Tianjin 300060, China
| | - X Yang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital Tianjin 300060, China
| | - Y Y Lei
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital Tianjin 300060, China
| | - X Y Xu
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital Tianjin 300060, China
| | - Y X Liu
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital Tianjin 300060, China
| | - Y H Guo
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital Tianjin 300060, China
| | - Y Pan
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital Tianjin 300060, China
| | - X H Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital Tianjin 300060, China
| | - H L Zhang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital Tianjin 300060, China
| | - K Fu
- Department of Pathology and Microbiology, UNMC, Omaha, USA
| | - B Meng
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital Tianjin 300060, China
| |
Collapse
|
37
|
Liao W, Zuo X, Lin G, Zhou Y, Fu Y, Cai S, Wei PP, Liu YX, Liu Y, Ma G, Bei JX. Microbial cell-free DNA in plasma of patients with sepsis: a potential diagnostic methodology. Discov Med 2020; 29:129-137. [PMID: 33002409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Sepsis is a life-threatening clinical condition demanding accurate and rapid diagnosis of the culprit pathogen, thereby to improve prognosis. Pathogen determination through blood culture is the gold standard for diagnosis but has limitations due to low sensitivity. Recently, circulating DNAs derived from pathogenic organisms were found in the plasma of patients with sepsis and were further proved to be more sensitive biomarkers for the diagnosis of the pathogen origin in sepsis. However, the fundamental molecular characteristics of circulating DNA in patients with sepsis remain unclear. Here, we used specific PCR and Sanger sequencing to verify the microbiology culture results via the corresponding plasma circulating DNA. We analyzed the composition and molecular characteristics of circulating DNA in septic patients using next-generation sequencing technology. We showed the presence of pathogen-derived circulating DNA in the plasma of patients with sepsis. The sizes of circulating DNA fragments derived from pathogenic bacteria showed a skewed unimodal distribution, while those derived from host cells showed a normal unimodal distribution. Lengths of fragments at peak concentration for both origins ranged from 150 bp to 200 bp, and reads mapping to pathogenic bacteria genome distributed uniformly on the reference. Our findings have improved our understanding of microbial circulating DNA in patients with sepsis as a potential methodology for the accurate diagnosis of sepsis, especially in light of an urgent need for such a diagnosis associated with the COVID-19 infection.
Collapse
Affiliation(s)
- Wei Liao
- Intensive Care Unit, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China
| | - Xiaoyu Zuo
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong, China
| | - Guowang Lin
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong, China
| | - Yaqing Zhou
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong, China
| | - Yonghong Fu
- Intensive Care Unit, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510641, Guangdong, China
| | - Shaohang Cai
- Intensive Care Unit, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China
| | - Pan-Pan Wei
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong, China
| | - Yu-Xiang Liu
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong, China
| | - Yang Liu
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong, China
| | - Gang Ma
- Intensive Care Unit, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China
- Corresponding author
| | - Jin-Xin Bei
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong, China
- Corresponding author
| |
Collapse
|
38
|
Li HY, Liu YX, Harvey L, Shafaeizadeh S, van der Beek EM, Han W. A mouse model of gestation-specific transient hyperglycemia for translational studies. J Endocrinol 2020; 244:501-510. [PMID: 31910155 DOI: 10.1530/joe-19-0516] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/11/2019] [Accepted: 12/23/2019] [Indexed: 11/08/2022]
Abstract
The prevalence of gestational diabetes mellitus (GDM) is estimated at 14% globally, and in some countries, such as Singapore, exceeds 20%. Both women and children exposed to GDM have an increased risk of later metabolic diseases, cardiovascular disease and other health issues. Beyond lifestyle changes and pharmaceutical intervention using existing type 2 diabetes medications for expecting women, there are limited treatment options for women with GDM; targeting better outcomes of potentially affected infants is unexplored. Numerous animal models have been generated for understanding of pathological processes of GDM development and for development of treatment strategies. These models, however, suffer from limited windows of opportunity to examine risk factors and potential intervention options. By combining short-term high-fat diet (HFD) feeding and low-dose streptozotocin (STZ) treatments before pregnancy, we have established a mouse model with marked transient gestation-specific hyperglycemia, which allows testing of nutritional and pharmacological interventions before, during and beyond pregnancy.
Collapse
Affiliation(s)
- H Y Li
- Laboratory of Metabolic Medicine, Singapore Bioimaging Consortium, A*STAR, Singapore, Republic of Singapore
| | - Y X Liu
- Laboratory of Metabolic Medicine, Singapore Bioimaging Consortium, A*STAR, Singapore, Republic of Singapore
- Danone Nutricia Research, Singapore, Republic of Singapore
| | - L Harvey
- Danone Nutricia Research, Utrecht, The Netherlands
| | | | - E M van der Beek
- Danone Nutricia Research, Utrecht, The Netherlands
- Department of Pediatrics, University Medical Centre Groningen, Groningen, The Netherlands
| | - W Han
- Laboratory of Metabolic Medicine, Singapore Bioimaging Consortium, A*STAR, Singapore, Republic of Singapore
- Institute of Molecular and Cell Biology, A*STAR, Singapore, Republic of Singapore
- School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, China
| |
Collapse
|
39
|
Wang XF, Yuan J, Zheng YJ, Chen J, Bao YM, Wang YR, Wang LF, Li H, Zeng JX, Zhang YH, Liu YX, Liu L. [Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen]. Zhonghua Er Ke Za Zhi 2020. [PMID: 32062875 DOI: 10.3760/cma.j.issn.0578-1310.2020.0008)] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Objective: To describe the characteristics of clinical manifestations and epidemiology of children with 2019 novel coronavirus (2019-nCoV) infection. Methods: All 34 children with laboratory-confirmed 2019-nCoV infection by quantitative real-time reverse transcription-PCR through nasopharyngeal swab specimens were admitted to the Third People's Hospital of Shenzhen from January 19 to Febuary 7, 2020. Clinical data and epidemiological history of these patients were retrospectively collected and analyzed. Results: Among the 34 cases, 14 were males, and 20 were females. The median age was 8 years and 11 months. No patients had underlying diseases. There were 28 children (82%) related with a family cluster outbreak. There were 26 children (76%) with a travel or residence history in Hubei Province. These patients could be categorized into different clinical types, including 22 (65%) common cases, 9 (26%) mild cases and 3 (8.8%) asymptomatic cases. No severe or critical cases were identified. The most common symptoms were fever (17 cases, 50%) and cough (13 cases, 38% ). In the 34 cases, the white blood cell counts of 28 cases (82%) were normal. Five cases had white blood cell counts more than 10×10(9)/L. One case had white blood cell counts less than 4×10(9)/L. Neutropenia and lymphopenia was found in one case, respectively. C-reactive protein levels and erythrocyte sedimentation rates were elevated in 1 and 5 case, respectively. Elevated procalcitonin was found in 1 case and D-Dimer in 3 cases. The levels of lactic dehydrogenase (LDH) were more than 400 U/L in 10 cases. The CT images of these patients showed bilateral multiple patchy or nodular ground-glass opacities and/or infiltrating shadows in middle and outer zone of the lung or under the pleura. Twenty patients were treated with lopinavir and ritonavir. Glucocorticoids and immunoglobulin were not used in any cases. All the cases improved and were discharged from hospital. Further following up was need. Conclusions: The clinical manifestations in children with 2019-nCoV infection are non-specific and are milder than that in adults. Chest CT scanning is heplful for early diagnosis. Children's infection is mainly caused by family cluster outbreak and imported cases. Family daily prevention is the main way to prevent 2019-nCoV infection.
Collapse
Affiliation(s)
- X F Wang
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - J Yuan
- Department of Infectious Disease, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - Y J Zheng
- Department of Respiration, Shenzhen Children's Hospital, Shenzhen 518026, China
| | - J Chen
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - Y M Bao
- Department of Respiration, Shenzhen Children's Hospital, Shenzhen 518026, China
| | - Y R Wang
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - L F Wang
- Department of Radiology, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - H Li
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - J X Zeng
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - Y H Zhang
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - Y X Liu
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - L Liu
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| |
Collapse
|
40
|
Wang XF, Yuan J, Zheng YJ, Chen J, Bao YM, Wang YR, Wang LF, Li H, Zeng JX, Zhang YH, Liu YX, Liu L. [Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen]. Zhonghua Er Ke Za Zhi 2020; 58:E008. [PMID: 32062875 DOI: 10.3760/cma.j.issn.0578-1310.2020.0008] [Citation(s) in RCA: 55] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To describe the characteristics of clinical manifestations and epidemiology of children with 2019 novel coronavirus (2019-nCoV) infection. Methods: All 34 children with laboratory-confirmed 2019-nCoV infection by quantitative real-time reverse transcription-PCR through nasopharyngeal swab specimens were admitted to the Third People's Hospital of Shenzhen from January 19 to Febuary 7, 2020. Clinical data and epidemiological history of these patients were retrospectively collected and analyzed. Results: Among the 34 cases, 14 were males, and 20 were females. The median age was 8 years and 11 months. No patients had underlying diseases. There were 28 children (82%) related with a family cluster outbreak. There were 26 children (76%) with a travel or residence history in Hubei Province. These patients could be categorized into different clinical types, including 22 (65%) common cases, 9 (26%) mild cases and 3 (8.8%) asymptomatic cases. No severe or critical cases were identified. The most common symptoms were fever (17 cases, 50%) and cough (13 cases, 38% ). In the 34 cases, the white blood cell counts of 28 cases (82%) were normal. Five cases had white blood cell counts more than 10×10(9)/L. One case had white blood cell counts less than 4×10(9)/L. Neutropenia and lymphopenia was found in one case, respectively. C-reactive protein levels and erythrocyte sedimentation rates were elevated in 1 and 5 case, respectively. Elevated procalcitonin was found in 1 case and D-Dimer in 3 cases. The levels of lactic dehydrogenase (LDH) were more than 400 U/L in 10 cases. The CT images of these patients showed bilateral multiple patchy or nodular ground-glass opacities and/or infiltrating shadows in middle and outer zone of the lung or under the pleura. Twenty patients were treated with lopinavir and ritonavir. Glucocorticoids and immunoglobulin were not used in any cases. All the cases improved and were discharged from hospital. Further following up was need. Conclusions: The clinical manifestations in children with 2019-nCoV infection are non-specific and are milder than that in adults. Chest CT scanning is heplful for early diagnosis. Children's infection is mainly caused by family cluster outbreak and imported cases. Family daily prevention is the main way to prevent 2019-nCoV infection.
Collapse
Affiliation(s)
- X F Wang
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - J Yuan
- Department of Infectious Disease, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - Y J Zheng
- Department of Respiration, Shenzhen Children's Hospital, Shenzhen 518026, China
| | - J Chen
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - Y M Bao
- Department of Respiration, Shenzhen Children's Hospital, Shenzhen 518026, China
| | - Y R Wang
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - L F Wang
- Department of Radiology, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - H Li
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - J X Zeng
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - Y H Zhang
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - Y X Liu
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| | - L Liu
- Department of Pediatrics, the Third People's Hospital of Shenzhen, Shenzhen 518020, China
| |
Collapse
|
41
|
Zhu SJ, Wang EH, Hamilton JH, Ramayya AV, Liu YX, Brewer NT, Luo YX, Rasmussen JO, Xiao ZG, Huang Y, Ter-Akopian GM, Oganessian T. Coexistence of Reflection Asymmetric and Symmetric Shapes in ^{144}Ba. Phys Rev Lett 2020; 124:032501. [PMID: 32031833 DOI: 10.1103/physrevlett.124.032501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/05/2019] [Revised: 12/24/2019] [Indexed: 06/10/2023]
Abstract
Level structures in the neutron-rich ^{144}Ba nucleus have been reinvestigated by measuring prompt γ rays in the spontaneous fission of ^{252}Cf. The previous s=+1 octupole band structure with reflection asymmetric shape has been expanded, and a side quadrupole band structure based on a 3^{+} state with reflection symmetric shape is identified. Thus, the results show the coexistence of reflection asymmetric and symmetric shapes in ^{144}Ba. This is a first identification of such a shape coexistence structure in a nuclear structure. The other structural characteristics are discussed.
Collapse
Affiliation(s)
- S J Zhu
- Department of Physics, Tsinghua University, Beijing 100084, People's Republic of China
| | - E H Wang
- Department of Physics, Vanderbilt University, Nashville, Tennessee 37235, USA
| | - J H Hamilton
- Department of Physics, Vanderbilt University, Nashville, Tennessee 37235, USA
| | - A V Ramayya
- Department of Physics, Vanderbilt University, Nashville, Tennessee 37235, USA
| | - Y X Liu
- Department of Physics, Huzhou University, Huzhou 313000, People's Republic of China
| | - N T Brewer
- Department of Physics, Vanderbilt University, Nashville, Tennessee 37235, USA
| | - Y X Luo
- Department of Physics, Vanderbilt University, Nashville, Tennessee 37235, USA
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - J O Rasmussen
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - Z G Xiao
- Department of Physics, Tsinghua University, Beijing 100084, People's Republic of China
| | - Y Huang
- Department of Physics, Tsinghua University, Beijing 100084, People's Republic of China
| | - G M Ter-Akopian
- Joint Institute for Nuclear Research, Ru-141980 Dubna, Russia Federation
| | - Ts Oganessian
- Joint Institute for Nuclear Research, Ru-141980 Dubna, Russia Federation
| |
Collapse
|
42
|
Liu YX, Zhang B, Zhang N, Liu ZL. Fabricating fiber probes for optical tweezers by an improved tube etching method. Appl Opt 2019; 58:7950-7956. [PMID: 31674346 DOI: 10.1364/ao.58.007950] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/28/2019] [Accepted: 09/06/2019] [Indexed: 06/10/2023]
Abstract
An improved tube etching method to fabricate high-quality fiber probes for optical tweezers by reserving a certain length of bare fiber to form a T-type composite structure was proposed and implemented. This method can overcome the impact of fiber types on the quality of probes in the conventional tube etching effectively. Based on the influence of gravity and diffusion on the motion of reactants, the analysis of formation mechanism was proposed for this method. This procedure retained the advantage of smooth surface in traditional tube etching but shortened the etching time. Our results also demonstrated that light transmittance of the probe fabricated by this method was improved by 6.8 times, resulting in a greater force in cells trapping. This work provided a way of designing and fabricating optical fiber tweezers with a high trapping efficiency.
Collapse
|
43
|
Miao L, Yang WN, Dong XQ, Zhang ZQ, Xie SB, Zhang DZ, Zhang XQ, Cheng J, Zhang G, Zhao WF, Xie Q, Liu YX, Ma AL, Li J, Shang J, Bai L, Cao LH, Zou ZQ, Li JB, Lyu FD, Liu H, Wang ZJ, Zhang MX, Chen LM, Liang WF, Gao H, Zhuang H, Zhao H, Wang GQ. [Combined anluohuaxianwan and entecavir treatment significantly improve the improvement rate of liver fibrosis in patients with chronic hepatitis B virus infection]. Zhonghua Gan Zang Bing Za Zhi 2019; 27:521-526. [PMID: 31357778 DOI: 10.3760/cma.j.issn.1007-3418.2019.07.009] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Objective: To explore the improvement rate of liver fibrosis in patients with chronic hepatitis B virus infection who received entecavir alone or in combination with anluohuaxianwan for 78 weeks. Methods: Patients with chronic HBV infection were randomly treated with entecavir alone or in combination with anluohuaxian for 78 weeks. Ishak fibrosis score was used for blind interpretation of liver biopsy specimens. The improvement in liver fibrosis condition before and after the treatment was compared. Student's t test and non-parametric test (Mann-Whitney U-Test and Kruskal-Wallis test) were used to analyze the measurement data. The categorical variables were analyzed by Chi-square test method and Spearman's rank correlation coefficient was used to test bivariate associations. Results: Liver fibrosis improvement rate after 78 weeks of treatment was 36.53% (80/219) and the progression rate was 23.29% (51/219). The improvement of liver fibrosis was associated to the degree of baseline fibrosis and treatment methods (P < 0.05). The improvement rate of hepatic fibrosis in patients treated with anluohuaxianwan combined with entecavir at baseline F < 3 (54.74%, 52/95) was significantly higher than that in patients treated only with entecavir (33.33%, 16/48), P = 0.016 and the progression rate of hepatic fibrosis (13.68%, 13/95) was lower than that in patients treated alone (18.75%, 9/48), P = 0.466. In patients with baseline F < 3, the proportion of patients with improved and stable liver fibrosis in the combined treatment group (68.1%, 32/47) was higher than that in the treatment group alone (51.7%, 15/29). Conclusion: Combined anluohuaxianwan and entecavir treatment can significantly improve the improvement rate of liver fibrosis in patients with chronic hepatitis B virus infection. Furthermore, it has the tendency to improve the stability rate and reduce the rate of progression of liver fibrosis.
Collapse
Affiliation(s)
- L Miao
- Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing 100034, China; Department of Hepatology, the Third Hospital of Qinhuangdao, Qinhuangdao 066000, China
| | - W N Yang
- Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing 100034, China
| | - X Q Dong
- Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing 100034, China
| | - Z Q Zhang
- Department of Hepatology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
| | - S B Xie
- Department of Infectious Disease, the Third Affiliated Hospital Sun Yat Sen University, Guangzhou 510630, China
| | - D Z Zhang
- Department of Infectious Diseases, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China; the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou 310058, China
| | - X Q Zhang
- Department of Infectious Diseases, the First Hospital Affiliated to Army Medical University, Chongqing 400038, China
| | - J Cheng
- Beijing Ditan Hospital, Capital Medical University, Beijing 100000, China
| | - G Zhang
- Department of Gastroenterology, the People's Hospital of Guangxizhuang Autonomous Region, Nanning 530021, China
| | - W F Zhao
- Department of Infectious Diseases, Xinxiang Medical University Third Hospital, Xinxiang 453000, China
| | - Q Xie
- Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China
| | - Y X Liu
- Department of Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen 518112, China
| | - A L Ma
- Department of Infectious Diseases, China-Japan Friendship Hospital, Beijing 100029, China
| | - J Li
- Department of Infectious Diseases, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
| | - J Shang
- Department of Infectious Diseases, the People's Hospital of Henan Province, Zhengzhou 450003, China
| | - L Bai
- Infectious Disease Department of West China Hospital, Sichuan University, Chengdu 610041, China
| | - L H Cao
- Department of Hepatology, the Third Hospital of Qinhuangdao, Qinhuangdao 066000, China
| | - Z Q Zou
- Yantai Infectious Diseases Hospital, Yantai 264000, China
| | - J B Li
- the First Affiliated Hospital of Anhui Medical University, Hehui 230022, China
| | - F D Lyu
- Beijing Youan Hospital, Capital Medical University, Beijing 100000, China
| | - H Liu
- Beijing Youan Hospital, Capital Medical University, Beijing 100000, China
| | - Z J Wang
- the 305 Hospital of PLA, Beijing 100300, China
| | - M X Zhang
- the 6th People's Hospital of Shenyang, Shenyang 110006, China
| | - L M Chen
- the 5th Medical Center of PLA General Hospital, Beijing 100039, China
| | - W F Liang
- First Affiliated Hospital of Zhejiang University, Hangzhou 310058, China
| | - H Gao
- Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing 100034, China
| | - H Zhuang
- Department of Microbiology and Center of Infectious Diseases, Peking University Health Science Center, Beijing 100191, China
| | - H Zhao
- Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing 100034, China
| | - G Q Wang
- Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing 100034, China; Department of Infectious Diseases, Peking University International Hospital, Beijing 102206, China; the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou 310058, China
| |
Collapse
|
44
|
Liu YX, Cai C, Huang J, Jia WP. [Strategy for dissemination of diabetes peer support through community health centers of Shanghai]. Zhonghua Nei Ke Za Zhi 2019; 58:389-391. [PMID: 31060150 DOI: 10.3760/cma.j.issn.0578-1426.2019.05.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Affiliation(s)
- Y X Liu
- Shanghai Jiao Tong University Affiliated 6th People's Hospital, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute, Shanghai 200233, China; Shanghai Jiao Tong University Affiliated 6th People's Hospital, National Office for Primary Diabetes Care, Shanghai 200233, China
| | - C Cai
- Shanghai Jiao Tong University Affiliated 6th People's Hospital, National Office for Primary Diabetes Care, Shanghai 200233, China
| | - J Huang
- Shanghai Jiao Tong University Affiliated 6th People's Hospital, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute, Shanghai 200233, China; Shanghai Jiao Tong University Affiliated 6th People's Hospital, National Office for Primary Diabetes Care, Shanghai 200233, China
| | - W P Jia
- Shanghai Jiao Tong University Affiliated 6th People's Hospital, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute, Shanghai 200233, China; Shanghai Jiao Tong University Affiliated 6th People's Hospital, National Office for Primary Diabetes Care, Shanghai 200233, China; Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated 6th People's Hospital, Shanghai Clinical Center for Diabetes, Shanghai 200233, China
| |
Collapse
|
45
|
Wang H, Hai S, Liu YX, Cao L, Liu Y, Liu P, Yang Y, Dong BR. Associations between Sarcopenic Obesity and Cognitive Impairment in Elderly Chinese Community-Dwelling Individuals. J Nutr Health Aging 2019; 23:14-20. [PMID: 30569063 DOI: 10.1007/s12603-018-1088-3] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
INTRODUCTION This study aimed to estimate the prevalence of sarcopenic obesity (SO) and the association between cognitive impairment and SO in a cohort of elderly Chinese community-dwelling individuals. METHODS A total of 948 elderly Chinese community-dwelling individuals aged 60-92 years were recruited. The participants were categorized into the following four groups according to their sarcopenia and obesity status: sarcopenic obese, sarcopenic, obese and non-sarcopenic, and non-obese group. Sarcopenia was defined as appendicular skeletal muscle index of <7.0 kg/m2 in men and <5.7 kg/m2 in women; obesity was defined as values greater than the upper two quintiles for body fat percentage stratified by gender of the study population; cognitive impairment was measured using the Mini-Mental State Examination and defined as a score of <24. RESULTS A total of 945 participants were included in the statistical analyses with a mean age of 68.76 ± 6.50 years. The prevalence of SO was 6.0% (7.3% in men and 4.8% in women). The sarcopenic obese (odds ratio [OR]: 2.550, 95% confidence interval [CI], 1.196-5.435) and obese (ORs: 2.141, 95% CI, 1.230-3.728) groups had significantly increased risk for cognitive impairment in fully adjusted model, respectively. CONCLUSION The SO prevalence in elderly Chinese community-dwelling individuals was relatively low (6.0%). The present study suggested SO was independently associated with cognitive impairment.
Collapse
Affiliation(s)
- H Wang
- Birong Dong, Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Chengdu 610041, China, E-mail address:
| | | | | | | | | | | | | | | |
Collapse
|
46
|
Sheng ZG, Shen C, Fan RM, Chao XJ, Liu YX, Zhu BZ. The Critical Role of X Chromosome-Linked Inhibitor of Apoptosis (XIAP) in Differential Synergism Induced by Pentachlorophenol and Copper-1,10-Phenanthroline Complex in Normal and Cancer Liver Cells. Toxicol Sci 2018; 168:339-348. [DOI: 10.1093/toxsci/kfy307] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Affiliation(s)
- Zhi-Guo Sheng
- Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China
| | - Chen Shen
- Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China
| | - Rui-Mei Fan
- Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China
| | - Xi-Juan Chao
- Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China
| | - Yu-Xiang Liu
- College of Chemistry and Chemical Engineering, Xinjiang Normal University, Urumqi, Xinjiang 830054, China
| | - Ben-Zhan Zhu
- Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China
- Linus Pauling Institute, Oregon State University, Corvallis, Oregon 97331
| |
Collapse
|
47
|
Liu YX, Wang RH. [An exploration on the factors of Jiao Xun's compilation and edit of Wu shi ben cao ( Wu's Materia Medica)]. Zhonghua Yi Shi Za Zhi 2018; 48:334-341. [PMID: 30669770 DOI: 10.3760/cma.j.issn.0255-7053.2018.06.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Wu shi ben cao (Wu's Materia Medica) written by Wu Pu was long lost. Jiao Xun of the Qing Dynasty was the first to compile and edit this book. The background of Jiao's work included: ① the necessary for revising Mao shi niao shou cao mu chong yu shi (Annotation to the Bird, Beast, Grass, Wood, Insect and Fish in Mao's Book of Songs); ② fond of medicine; ③ the feeling of retaining hometown documents; ④ the influence of the traditional style of compilation and edit; whereas Jiao's intrinsic characteristics included: ① a wealth of books and convenient borrowing environment; ② the habit of reading and transcription; ③ the thought of pu xue (the School of ancient textual criticism), that is "using the Confucian's method to study medical classics" ; ④ the methods of studying classics based on the classical texts; ⑤ high literate level of compilation of losing texts of classics. The original texts of Wu shi ben cao was thus resumed preliminarily by Jiao Xun's work.
Collapse
Affiliation(s)
- Y X Liu
- Wulian County Administration of Traditional Chinese Medicine of Shandong Province, Rizhao, 262300
| | - R H Wang
- People's Hospital of Wulian County, Rizhao, 262300 , China
| |
Collapse
|
48
|
Peng P, Sun SZ, Liu YX, Liu XM, Mintova S, Yan ZF. Combined alkali dissolution and re-assembly approach toward ZSM-5 mesostructures with extended lifetime in cumene cracking. J Colloid Interface Sci 2018; 529:283-293. [PMID: 29909358 DOI: 10.1016/j.jcis.2018.06.013] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2018] [Revised: 06/02/2018] [Accepted: 06/05/2018] [Indexed: 11/27/2022]
Abstract
The basis and contribution of mesopores created in ZSM-5 structures at different treatment conditions are systematically investigated. The results reveal that the mesopores originated from the alkali dissolution of pristine ZSM-5 are mainly intracrystalline and they contribute to excessive Brønsted acid sites, while the mesopores originated from the re-assembly of alkali dissolved aluminosilicate species possess Lewis acid sites. These ZSM-5 mesostructures showed an extended lifespan during the cracking of cumene (88.0%) in comparison to the pristine ZSM-5 (27.0%) after 460 min. The zeolite mesostructures obtained in this study could be used as a base for further design of new porous materials with desired acidic properties.
Collapse
Affiliation(s)
- Peng Peng
- State Key Laboratory of Heavy Oil Processing, China University of Petroleum, Qingdao 266580, China; Normandie Univ, ENSICAEN, UNICAEN, CNRS, Laboratoire Catalyse et Spectrochimie, 14000 Caen, France
| | - Shu-Zhuang Sun
- State Key Laboratory of Heavy Oil Processing, China University of Petroleum, Qingdao 266580, China
| | - Yu-Xiang Liu
- State Key Laboratory of Heavy Oil Processing, China University of Petroleum, Qingdao 266580, China; College of Chemical Engineering, Qingdao University of Science & Technology, Qingdao 266042, China
| | - Xin-Mei Liu
- State Key Laboratory of Heavy Oil Processing, China University of Petroleum, Qingdao 266580, China
| | - Svetlana Mintova
- State Key Laboratory of Heavy Oil Processing, China University of Petroleum, Qingdao 266580, China; Normandie Univ, ENSICAEN, UNICAEN, CNRS, Laboratoire Catalyse et Spectrochimie, 14000 Caen, France
| | - Zi-Feng Yan
- State Key Laboratory of Heavy Oil Processing, China University of Petroleum, Qingdao 266580, China.
| |
Collapse
|
49
|
Niu Y, Zhou G, Wang Y, Qin J, Ping J, Zhang Q, Han BW, Liu YX, Yang C, Zhai Y, Zhang H, He F, Mai HQ, Bei JX, Li Y, Zhou G. Association of MCP-1 promoter polymorphism with susceptibility to nasopharyngeal carcinoma. J Cell Biochem 2018; 120:6661-6670. [PMID: 30368911 DOI: 10.1002/jcb.27962] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2018] [Accepted: 10/02/2018] [Indexed: 01/06/2023]
Abstract
Nasopharyngeal carcinoma (NPC) is prevalent among populations from southern China and is influenced by both genetic and environmental risk factors. The monocyte chemoattractant protein-1 (MCP-1), a member of cysteine-cysteine chemokine family, plays critical roles in cancers. A polymorphism within the MCP-1 promoter, rs1024611, has been shown to be significantly associated with the risk of several cancers. Our purpose was to assess the role of rs1024611 in NPC susceptibility. By polymerase chain reaction-restriction fragment length polymorphism method, we genotyped rs1024611 in 593 patients with NPC (cases) and 480 cancer-free subjects (controls) among Guangxi population from southern China. We observed that the G allele of rs1024611 was significantly associated with the increased risk of NPC in an additive model and dominant model, respectively (P = 0.018 and 0.010, odds ratio = 1.25 and 1.41, respectively). No appreciable variation of the effects was found across the subgroups stratified by age, sex, nationality, smoking and drinking status, and smoking level. In addition, significantly higher messenger RNA (mRNA) expression level of MCP-1 was observed in NPC tissues than that in normal nasopharyngeal tissues, and the G allele of rs1024611 was significantly associated with elevated mRNA expression level of MCP-1 in Epstein-Barr virus-transformed lymphocytes. In conclusion, our findings suggested that rs1024611 at the MCP-1 promoter may be a risk factor for NPC. Further studies with larger sample size are necessary to confirm these findings.
Collapse
Affiliation(s)
- Yuguang Niu
- Department of Genomics & Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, China.,ENT Department, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China
| | - Guangming Zhou
- Department of Genomics & Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, China.,Department of Genomics & Proteomics, National Engineering Research Center for Protein Drugs, Beijing, China.,Department of Genomics & Proteomics, National Center for Protein Sciences at Beijing, Beijing, China
| | - Yahui Wang
- Department of Genomics & Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, China.,Department of Genomics & Proteomics, National Engineering Research Center for Protein Drugs, Beijing, China.,Department of Genomics & Proteomics, National Center for Protein Sciences at Beijing, Beijing, China.,Department of Genomics & Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, China
| | - Jianing Qin
- Department of Genomics & Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, China
| | - Jie Ping
- Department of Genomics & Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, China.,Department of Genomics & Proteomics, National Engineering Research Center for Protein Drugs, Beijing, China.,Department of Genomics & Proteomics, National Center for Protein Sciences at Beijing, Beijing, China
| | - Qing Zhang
- Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China
| | - Bo-Wei Han
- Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
| | - Yu-Xiang Liu
- Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
| | - Chenning Yang
- Department of Genomics & Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, China.,Department of Genomics & Proteomics, National Engineering Research Center for Protein Drugs, Beijing, China.,Department of Genomics & Proteomics, National Center for Protein Sciences at Beijing, Beijing, China
| | - Yun Zhai
- Department of Genomics & Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, China.,Department of Genomics & Proteomics, National Engineering Research Center for Protein Drugs, Beijing, China.,Department of Genomics & Proteomics, National Center for Protein Sciences at Beijing, Beijing, China
| | - Hongxing Zhang
- Department of Genomics & Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, China.,Department of Genomics & Proteomics, National Engineering Research Center for Protein Drugs, Beijing, China.,Department of Genomics & Proteomics, National Center for Protein Sciences at Beijing, Beijing, China
| | - Fuchu He
- Department of Genomics & Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, China.,Department of Genomics & Proteomics, National Engineering Research Center for Protein Drugs, Beijing, China.,Department of Genomics & Proteomics, National Center for Protein Sciences at Beijing, Beijing, China.,Department of Genomics & Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, China
| | - Hai-Qiang Mai
- Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
| | - Jin-Xin Bei
- Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China
| | - Yuanfeng Li
- Department of Genomics & Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, China.,Department of Genomics & Proteomics, National Engineering Research Center for Protein Drugs, Beijing, China.,Department of Genomics & Proteomics, National Center for Protein Sciences at Beijing, Beijing, China
| | - Gangqiao Zhou
- Department of Genomics & Proteomics, State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing, China.,Department of Genomics & Proteomics, National Engineering Research Center for Protein Drugs, Beijing, China.,Department of Genomics & Proteomics, National Center for Protein Sciences at Beijing, Beijing, China.,Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China
| |
Collapse
|
50
|
Qin GJ, Zhao YZ, Liu YX, Li C, Cao J, Cheng QC, Xiao XH, Lu Q. [Study on the effects of total flavonoids from litchi nucleus on nuclear translocation of nuclear factor-kappa B and related protein expression in rat hepatic stellate cell]. Zhonghua Gan Zang Bing Za Zhi 2018; 26:535-539. [PMID: 30317778 DOI: 10.3760/cma.j.issn.1007-3418.2018.07.011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: The effect of total flavonoids of litchi (TFL) on nuclear translocation of nuclear factor-kappa B (NF- kappa B) in rat hepatic stellate cell line (HSC-T6) induced by transforming growth factor - beta 1 (TGF- beta 1) in vitro was studied to explore the mechanism of action of anti-hepatic fibrosis drugs. Methods: HSC-T6 was cultured in vitro, induced by TGFβ1 for 24 h, and then treated with TFL at 125, 250 and 500 μg/ml for 48 h. The effect of TFL on NF-κB nuclear translocation in HSC-T6 was observed by confocal laser microscopy. The effects of TFL on the expression of TLR4, p-IκB ɑ, p-NF-κB p65, NF-κB and Collagen I protein were detected by western blot. The expressions of TLR4 and p-NF-κB p65 were detected by immunofluorescence. Data were presented as mean±SEM. Homogeneity test of variance was performed and then followed by one-way analysis of variance (ANOVA). The multiple comparisons between groups were performed by LSD test. P < 0.05 was considered statistically significant. Results: Confocal laser scanning microscopy showed TFL inhibited the nuclear translocation of NF-κB in activated HSC-T6 in a concentration-dependent manner and TFL down regulated the protein expression levels of TLR4, p-IκB ɑ, p-NF-κB p65, NF-κB and collagen I protein in HSC-T6 in a concentration-dependent manner. Conclusion: The mechanism of TFL against hepatic fibrosis may be related to the inhibition of nuclear translocation of NF-κb in the activated HSC-T6 and the expression of TLR4, P-iκbɑ, P-nf-κb p65, NF-κb and collagen I protein in HSC-T6.
Collapse
Affiliation(s)
- G J Qin
- Gastroenterology Department, Affiliated Hospital of Guilin Medical University, Guilin 541001, China
| | - Y Z Zhao
- Gastroenterology Department, Affiliated Hospital of Guilin Medical University, Guilin 541001, China
| | - Y X Liu
- Gastroenterology Department, Affiliated Hospital of Guilin Medical University, Guilin 541001, China
| | - C Li
- Gastroenterology Department, Affiliated Hospital of Guilin Medical University, Guilin 541001, China
| | - J Cao
- Gastroenterology Department, Affiliated Hospital of Guilin Medical University, Guilin 541001, China
| | - Q C Cheng
- Guangxi Medical University, Nanning 530021, China
| | - X H Xiao
- Gastroenterology Department, Affiliated Hospital of Guilin Medical University, Guilin 541001, China
| | - Q Lu
- Gastroenterology Department, Affiliated Hospital of Guilin Medical University, Guilin 541001, China
| |
Collapse
|